date prepared june, 2017 curriculum vitae colleen j...

Date prepared – June, 2017

CURRICULUM VITAE

COLLEEN J. MAXWELL

I. BIOGRAPHICAL DATA

Address: 817 Creekside Drive DOB: January 30, 1965

Waterloo, Ontario Citizenship: Canadian

N2V 2S6

Office Telephone: (519) 888-4567 x21396

Fax: (519) 883-7580

email: [email protected]

Present rank: Professor / with Tenure (effective July 1, 2011)

Department(s): School of Pharmacy

Faculty: Science

Institution: University of Waterloo

II. ACADEMIC RECORD

Final Degree: PhD

Date Completed: 1995

Specialty: Health Studies (Epidemiology of Alzheimer’s Disease and Related

Disorders)

Institution/City/Country: University of Waterloo / Waterloo ON / Canada

(i) Undergraduate

Sept 1984 – Oct 1988 Honours Bachelor of Science (Dean’s Honour List)

Health Studies (Biomedical Stream)

Faculty of Applied Health Sciences

University of Waterloo / Waterloo ON / Canada

(ii) Graduate & Post-Doctoral

May 1989 – Oct 1991 Master of Arts

Gerontology

Faculty of Arts


Jan 1992 – Oct 1995 Doctor of Philosophy

Health Studies (Epidemiology of Alzheimer’s Disease and Related

Disorders)

Faculty of Applied Health Sciences


Oct 1994 – Oct 1996 Post-doctoral Fellowship

Clinical Epidemiology Unit & Research Department

Élisabeth-Bruyère Health Centre / Ottawa ON / Canada

Oct 1994 – Sept 1997 Clinical Researcher

Drugs Directorate (with Dr. C. Ineke Neutel)

Health Canada / Ottawa ON / Canada

Colleen J. Maxwell cont’d of 56

(iii) Post-Graduate Courses

April 19-20, 2013 Longitudinal Data Analysis Using SAS, Statistical Horizons (Dr. Paul

Allison), Philadelphia, PA

Aug 17, 2008 Advanced Topics in Pharmacoepidemiology, 24th International Conference

on Pharmacoepidemiology & Therapeutic Risk Management, Copenhagen,

Denmark.

July 9-13, 2007 Event History & Survival Analysis, Statistical Horizons (Dr. Paul Allison),

Philadelphia, PA

III. AWARDS AND DISTINCTIONS

2016 Outstanding Performance Award ~ Faculty of Science, University of Waterloo

Oct 2007 Watanabe Award for Overall Excellence ~ Faculty of Medicine, University of

Calgary

2006-2013 Health Scholar Award

Alberta Heritage Foundation for Medical Research (AHFMR)

2003 - 2006 Population Health Investigator Award

Alberta Heritage Foundation for Medical Research (AHFMR)

2002 – 2007 CIHR New Investigator Award, Institute of Aging Partnership Program.

2000 – 2003 Population Health Investigator Award and Establishment Grant ($242,000),

Alberta Heritage Foundation for Medical Research.

1995 Nominated for Gold Medal Award (PhD Dissertation), Faculty of Applied Health

Sciences, University of Waterloo

1994-1995 Ontario Graduate Scholarship, University of Waterloo

1994 University of Waterloo – Graduate Scholarship





1987 Department of Health Studies – Upper Year Scholarship

1986-1987 Department of Health Studies – Lois Matthews Scholarship

1984 University of Waterloo – Entrance Scholarship

IV. ACADEMIC / OTHER APPOINTMENTS

Oct 2011 – present Adjunct Scientist, Institute for Clinical Evaluative Sciences (ICES),

Toronto, ON

Oct 2011 – present Professor (cross-appointment), School of Public Health & Health Systems,

University of Waterloo, Waterloo, ON

July 2011 – present Adjunct Professor, Department of Community Health Sciences, University

of Calgary, Calgary, AB

July 2011 – present Member – Institute for Public Health (IPH), University of Calgary.

April 2010 – June 2011 Professor, Departments of Community Health Sciences & Medicine,

Faculty of Medicine, University of Calgary, Calgary, AB

July 2009 – June 2011 Member – Calgary Institute for Population & Public Health (CIPPH),

University of Calgary.


Jan 2005 – June 2011 Full Member – Hotchkiss Brain Institute (HBI), University of Calgary.

June 2003 – Mar 2010 Associate Professor, Departments of Community Health Sciences &

Medicine, Faculty of Medicine, University of Calgary, Calgary, AB

Sept 2003 – Aug 2004 Research Consultant – Care of the Elderly Residency Program in Family

Medicine, Faculty of Medicine, University of Calgary

Sept 2002 – June 2009 Fellow – Centre for Health & Policy Studies (CHAPS), University of

Calgary

July 2001 – April 2004 Research Director – Residency Program in Geriatric Medicine, Faculty of

Medicine, University of Calgary

Nov 1999 – June 2011 Fellow of the Institute of Health Economics – a centre of excellence in

health & pharmaceutical outcomes, policy & economic research,

Edmonton, AB

Jan 1999 – 2002 Alberta Health, Health Services Utilization Researcher & Member of

Aging Workgroup of Alberta Centre for Health Services Utilization

Research (ACHSUR)

Dec 1997 – May 2003 Assistant Professor (Health Service Research in Geriatrics –co- funded by

Strafford Chair in Geriatric Medicine), Departments of Community Health

Sciences & Medicine, Faculty of Medicine, University of Calgary, Calgary,

AB

Oct 1997 – Dec 1997 Visiting Professor and Research Consultant (Geriatric Medicine), Centre

for Health Services Studies, University of Kent at Canterbury, Canterbury,

Kent, United Kingdom

Feb 1996 – Sept 1997 Adjunct Assistant Professor, Department of Family Medicine, Faculty of

Medicine, University of Ottawa, Ottawa, ON

Jan 1996 – Sept 1997 Assistant Director of Research, Sisters of Charity of Ottawa (SCO)

Hospital Élisabeth-Bruyère Pavilion – Clinical Epidemiology Unit, Ottawa,

ON

June 1993 – Sept 1994 Assistant Director of Research, Freeport Hospital (Institute for Research on

Aging and Health), Kitchener, ON

May 1989 – June 1993 Research Analyst and Consultant, Freeport Hospital (Research

Department), Kitchener, ON

V. EDUCATIONAL ACTIVITIES

(i) Undergraduate

July 2016 Lecturer, Pharm 111 – A Systems Approach to the Study of the Human

Body Part 2.

Nov 2015 Lecturer, Hlth 201/Geron 201: Aging & Health, Medications in Older

Adults.

May 2017; May 2016 Lecturer, IPFC-3 [Pharm 222], Introduction to Evidence Based Medicine,

June 2015 Systematic Review & Meta-Analysis.

July – Aug 2017 Lecturer, Pharm 466 – Advanced Geriatric Care, School of Pharmacy,

Jan – Feb 2017 University of Waterloo

July – Aug 2016

Jan – Feb 2016

July – Aug 2015

Jan – Feb 2015

May – Aug 2014,

Jan – April 2014

Jan – April 2013, Course Coordinator & Lecturer, Pharm 466 - Advanced Geriatric Care,


May-Aug 2012 School of Pharmacy, University of Waterloo.

July – Aug 2017 Course Coordinator, Pharm 491 – Seminars in Pharmacy 3, School of

Jan – Feb 2017 Pharmacy, University of Waterloo

July – Aug 2016

Jan – Feb 2016

July – Aug 2015

Jan – Feb 2015.

Jan – April 2014 Course Coordinator, Pharm 490 – 4th Year Seminar, School of Pharmacy,

University of Waterloo.

May-Aug 2013, Course Coordinator, Pharm 491 – 4th Year Seminar, School of Pharmacy,

May-Aug 2012 University of Waterloo.

Mar 2012 Lecturer (Introduction to Pharmacoepidemiology), Pharm 290 - Seminars

in Pharmacy-1, School of Pharmacy, University of Waterloo.

Feb 2012 Lecturer (Pharmacoepidemiology & Applications of Administrative

Databases), Multidisciplinary Seminar on Aging (Hlth/Geron 400), School

of Public Health & Health Systems, University of Waterloo.

August 2006 Instructor / Preceptor, Small Group Sessions – Healthy Populations

(MDCN 340)

Jan 2003, Jan 2001, Course Lecturer, Epidemiology of Aging (MDCN 423 - Aging and

Jan 2000, Feb 1999, Elderly Course), Dept. of Medicine, University of Calgary

Feb 1998

Oct 5, 2000 Instructor, Small Group Session for Unit 1 – Research Methods and

Evidence-based Medicine Course (MDCN 340), Faculty of Medicine,

University of Calgary

(ii) Graduate

Nov 2016 Lecturer (Aging, multimorbidity and pharmacotherapy), Hlth 750 –

Fundamentals of Aging, Health and Well-being, Faculty of Applied Health

Sciences, University of Waterloo

June 2015 Course Coordinator and Instructor, One Day Workshop on Systematic

Review & Meta-Analysis (University Wide).

Jan – April 2014 Instructor & Coordinator, HSG 620 – Selected Topics Course –

Introduction to Pharmacoepidemiology, SPHHS, University of Waterloo.

Nov 2015, 2014 Lecturer (Pharmacoepidemiology: methods and applications), Pharm 610 –

Topics in Drug Development, School of Pharmacy, University of Waterloo.

June 2013, 2012 Lecturer (Pharmacoepidemiology: methods and applications), Pharm 610 -

Topics in Drug Development, School of Pharmacy, University of Waterloo.

Winter terms: Co-Instructor & Coordinator, Advanced Epidemiology (MDSC 709)

2011, 2010, 2009

Feb 2010, March 2008, Lecturer (Drug Data), Administrative Data Analysis Methodology (MDSC

Feb 2007, Feb 2006 659.07)


Jan 2008 Lecturer (Cohort Studies), Advanced Epidemiology (MDSC 709)

Winter terms 2005, Course Instructor, Health Services for the Elderly (MDSC 645.08), Dept. of

2003, 2001, 1999 Community Health Sciences, University of Calgary

June – Sept 2003 Course Instructor, Clinical Trials and Aging Research (MDSC 755.37 ~

Directed Study Course), Dept. of Community Health Sciences, University

of Calgary

Sept – Dec 2000 Course Co-Instructor, Health Research Methods I (Fundamentals of

Epidemiology: MDSC 647.01), Dept. of Community Health Sciences,


Sept 8, 2000 Co-Instructor, Introduction to Epidemiology & Biostatistics (Introduction

to Community Health: MDSC 645.04), Dept. of Community Health

Sciences, University of Calgary

Sept – Dec 1999 Course Instructor, Pharmacoepidemiology and Aging (MDSC 755.25-

Directed Study Course), Dept. of Community Health Sciences, University

of Calgary

Jan – April 1997 Course Instructor, Introduction to Gerontology, Dept. of Psychology,

Carleton University, Ottawa

Jan – April 1992 Teaching Assistant – Dr. C. Schwenger (Health Care Policies/Programs for

Elderly) Program in Gerontology, University of Waterloo, Waterloo, ON

Graduate Student Supervision

Sept 2016 – present Supervisor – Sarah Leslie (MSc), School of Public Health & Health

Systems, University of Waterloo.

Nov 2014 – Sept 2015 Co-Supervisor – Elizabeth Freiheit (PhD-Epi), Department of Community

Health Sciences, University of Calgary. (Successfully defended PhD Sept

15, 2015).

Sept 2014 – Sept 2016 Supervisor – Eleanor Pineau (MSc), School of Public Health & Health

Systems, University of Waterloo. (Successfully defended MSc Sept 28,

2016).

Sept 2013 – Aug 2015 Supervisor – Kathryn Stock (MSc), School of Public Health & Health

Systems, University of Waterloo. (Successfully defended MSc July 27,

2015).

Sept 2012 – May 2013 Supervisor – Mary Vu (PhD), School of Public Health & Health Systems,

University of Waterloo - withdrew.

Sept 2011 – Oct 2016 Co-Supervisor – Dr. Monica Cepoiu-Martin (PhD in Health Research),

Dept. of Community Health Sciences, University of Calgary. (received

AXA Doctoral Fellowship, 2011-2014; Successfully defended PhD Oct 31,

2016).

May 2008 – July 2012 Co-Supervisor – Elizabeth Freiheit, Research Associate (received AHFMR

Summer Studentship Award and is a CIHR Strategic Training Fellow in

TORCH (Tomorrow's Research Cardiovascular Health Professionals)).

Sept 2005 – Sept 2009 Supervisor – Morgan Aho (MSc in Epidemiology), Dept. of Community

Health Sciences, University of Calgary. (Successfully defended MSc Sept

8, 2009).

Sept 2004 – Dec 2008 Supervisor – Alison Supina (PhD in Epidemiology), Dept. of Community

Health Sciences, University of Calgary. (received AHFMR Studentship,

2005-08; Successfully defended PhD Oct 20, 2008).

Sept 2004 – Sept 2007 Supervisor – Megan Piket (MSc in Health Research), Dept. of Community

Health Sciences, University of Calgary (received studentship from

Strafford Foundation Chair in Alzheimer Research; discontinued program

for medical leave).


Sept 2001 – Sept 2006 Supervisor – Jennifer D. Walker (PhD in Epidemiology), Dept. of

Community Health Sciences, University of Calgary (received AHFMR

Studentship, 2002-03 & 2003-04; Successfully defended PhD June 29,

2006).

Sept 2001 – 2006 Supervisor – Charlemaigne C. Victorino (PhD in Epidemiology), Dept. of

Community Health Sciences, University of Calgary. Discontinued program

and completed a PhD in Sociology in 2014, University of Calgary.

Sept 1999 – April 2000 Co-Supervisor – Michelle I. Howard (PhD in Epidemiology), Dept. of

Community Health Sciences, University of Calgary

Sept 1998 – Sept 2001 Supervisor – Shelly A. Vik (MSc in Epidemiology), Dept. of Community

Health Sciences, University of Calgary (thesis nominated for Gold Medal;

Successfully defended MSc Sept 11, 2001)

Graduate Student Supervisory Committees

Feb 2017 – present Supervisory Committee Member – Danielle Fearon (MSc), School of

Public Health & Health Systems, University of Waterloo

June 2015 – Jan 2017 Supervisory Committee Member – Michael MacKinley (MSc), School of

Public Health & Health Systems, University of Waterloo.

April 2014 – Dec 2015 Supervisory Committee Member – Mushaal Ijaz (MSc), School of Public

Health & Health Systems, University of Waterloo.

Jan 2014 – present Supervisory Committee Member (and Supervisor for Comprehensive Exam

B) – Maryam Iraniparast (PhD), School of Public Health & Health

Systems, University of Waterloo.

Jan 2013 – Dec 2013 Thesis Proposal Committee Member – Yannick Fortin (PhD), Population

Health & Pharmacoepidemiology, University of Ottawa.

Nov 2013 – April 2015 Supervisory Committee Member – Erica Ihn (MSc), School of Public

Health & Health Systems, University of Waterloo.

April 2012 – April 2014 Supervisory Committee Member – Sara Ibrahim (MSc), Pharmacy,

University of Waterloo.

Dec 2011 – June 2013 Supervisory Committee Member – Symron Bansal (MSc), Kinesiology,

Applied Health Sciences, University of Waterloo.

May 2011 – June 2014 Supervisory Committee Member – Kirsten Fiest (PhD Epidemiology), Dept

of Community Health Sciences, University of Calgary.

Feb 2010 – June 2013 Supervisory Committee Member – Trevor Cook (MSc Epidemiology – MD

program), Dept of Community Health Sciences, University of Calgary.

Jan 2010 – June 2013 Supervisory Committee Member – Shannon Reynolds (MSc Health

Management Policy & Evaluation), University of Toronto.

Jan 2010 – Nov 2014 Supervisory Committee Member – Elizabeth Freiheit (PhD Biostatistics),

Dept of Community Health Sciences, University of Calgary.

Jan 2008 – April 2011 Supervisory Committee Member – Andrea Foebel (PhD Health Studies),

Dept. of Health Studies & Gerontology, University of Waterloo.

(Successfully defended PhD April 26, 2011).

Dec 2007 – Dec 2010 Supervisory Committee Member – Devika Kashyap (MSc, Clinical

Neurosciences), University of Calgary.

Sept 2007 – Aug 2014 Supervisory Committee Member – Donna Marcy-Edwards (PhD

Interdisciplinary Studies), University of Calgary. (Successful defended

PhD Aug 26, 2014)

Sept 2007 – Sept 2009 Supervisory Committee Member – Micaela Jantzi (MSc Health Studies &

Gerontology), University of Waterloo. (Successfully defended MSc Sept

30, 2009)

Feb 2006 – present Supervisory Committee Member – Sue Townsend (PhD Rehab &

Disability Studies), University of Calgary. [ongoing medical leave]

Feb 2006 – Sept 2008 Supervisory Committee Member – Haifeng Zhu (MSc Epidemiology),

Dept. of Community Health Sciences, University of Calgary


Feb 2006 – Feb 2010 Supervisory Committee Member – Deirdre Hennessy (PhD Epidemiology),


CIHR Studentship 2007 – 2010) – successfully defended Feb 25,2010.

April 2005 – June 2008 Supervisory Committee Member – Joseph Amuah (PhD Biostatistics),


AHFMR Studentship, 2006 – 2009).

April 2003 – Oct 2003 Supervisory Committee Member – Kelsey Juzwishin (MSc Epidemiology),


March 2003 – Oct 2003 Supervisory Committee Member – Lianne Barnieh (MSc Cancer

Epidemiology), University of Calgary

Jan 2002 – Sept 2005 Supervisory Committee Member – Diane Galbraith (MSc Clinical

Epidemiology), Dept. of Community Health Sciences, University of

Calgary

Sept 2001 – 2002 Supervisory Committee Member – Matthew Hicks (PhD), Dept. of


Feb 2000 – Oct 2003 Supervisory Committee Member – Christa Sutton (MN), Faculty of

Nursing, University of Calgary

March 2000 – Sept 2002 Supervisory Committee Member – Dr. Larissa Roux (PhD), Dept. of


April 2000 – March 2002 Supervisory Committee Member – Dr. Cristina Stoian (MSc in Health

Research), Dept. of Community Health Sciences, University of Calgary

Sept 1996 – Dec 1998 Supervisory Committee Member – Katherine E. Turcotte (MSc in

Epidemiology), Dept. of Epidemiology & Community Medicine,

University of Ottawa

Graduate Student Examination Committees

Aug 2014 Examination Committee Member (external examiner), Andrea Burden

(PhD), Pharmaceutical Sciences, University of Toronto

April 2012 Examination Committee Member (external examiner), Longyang Wu

(PhD), Biostatistics, University of Waterloo.

June 2008 Examination Committee Member (external examiner), Pavanjit Singh

Ahluwalia (MSc), Dept. of Neuroscience, University of Calgary.

April 2005 Examination Committee Member (external examiner), Leah Clyburn

(PhD), Psychology, Lakehead University.

Dec 2004 Examination Committee Member (external examiner), Liza Stelmach

(PhD), Clinical Psychology, University of Calgary

March 2003 Examination Committee Member (external examiner), Leanne Yunker

(MSc), Dept. of Medicine, University of Calgary

July 2001 Examination Committee Member (external), Charlemaigne C. Victorino

(MA), Dept. of Sociology, University of Calgary

June 2000 Examination Committee Member, Dr. Judy MacDonald (MCM

Comprehensive Examination), Dept. of Community Health Sciences,


June 2000 External examiner, Debra Hartley (MSW Final Comprehensive

Examination), Faculty of Social Work, University of Calgary

May 2000 Examination Committee Member, Dr. Larissa Roux (PhD Candidacy

Examination), Dept. of Community Health Sciences, University of Calgary

May 1997 External examiner, MA dissertation, Gerontology, University of Waterloo

Jan 1997 External examiner, Ph.D. dissertation, Dept. of Psychology, Carleton

University


(iii) Postgraduate (Research & Clinical Fellows)

Feb 2016 – present Mentor – Dr. Julia Kirkham, Clinical Fellow ~ Geriatric Psychiatry,

Queens’ University, funded by Canadian Frailty Network

Jan 2016 – present Co-Supervisor – Vasily Giannakeas, Analyst, Institute for Clinical

Evaluative Sciences, Toronto

June 2015 – present Co-Supervisor – Michael Campitelli, Analyst & Epidemiologist, Institute

for Clinical Evaluative Sciences, Toronto

Dec 2015 – present Co-Supervisor – Laura MacLagan, Analyst & Epidemiologist, Institute for

Clinical Evaluative Sciences, Toronto

Sept 2014 – present Co-Supervisor – Christina Diong, Analyst, Institute for Clinical Evaluative

Sciences, Toronto

Sept 2014 – 2015 Supervisor – Cindy Yip, Research Associate, School of Pharmacy,

University of Waterloo

April 2014 – present Co-Supervisor – Luke Mondor, Analyst & Epidemiologist, Institute for

Clinical Evaluative Sciences, Toronto & Ottawa

April 2014 – present Co-Supervisor – Sima Gandhi MSc, Analyst & Epidemiologist, Institute

for Clinical Evaluative Sciences, Toronto

April 2014 – 2015 Co-Supervisor – Ryan Ng, Institute for Clinical Evaluative Sciences,

Toronto

Jan 2013 – present Supervisor – Maryam Iraniparast (PhD, School of Public Health & Health

Systems) University of Waterloo.

Sept 2012 – 2015 Supervisor – Mary Vu (MSc), Research Associated, School of Pharmacy,


May 2012 – 2013 Supervisor – Meaghan Zehr, Research Associate, School of Pharmacy,


June 2011 - 2013 Co-Supervisor, Jessica Leah, Analyst & Epidemiologist, Institute for

Clinical Evaluative Sciences, Toronto.

Sept 2010 – 2012 Supervisor – Andrea Soo (PhD Biostatistics), Community Health Sciences,

University of Calgary.

Jan 2009 – present Supervisor – Joseph Amuah PhD University of Calgary, CIHI and

University of Ottawa.

Jan 2008 – 2012 Supervisor – Erin Gilbart, Research Associate, University of Calgary

Nov 2005 – 2010 Supervisor – Jane (Jian) Kang (PhD Biostatistics), CHAPS, University of

Calgary, Focus on Aging & Health-Related Quality of Life.

July 2002 – Dec 2002 Supervisor – Sudarat Sittisombut (Visiting Scholar & PhD candidate,

Program in the College of Public Health of Chulalongkorn University,

Bangkok, Thailand), Focus on Geriatric Health Care in Canada

Oct 2001 – 2007 Supervisor – Shelly A. Vik (Research Assistant – Masters prepared), Focus

on Pharmacoepidemiology and Aging Research

Sept 2001 – 2003 Supervisor – Susan Jelinski (Post-Doctoral Fellow), Funded by the Institute

of Health Economics

Jan 2001 – 2007 Supervisor – Jenny Zhang (Research Assistant – Masters prepared), Funded

by the Institute of Health Economics

Nov 2001 – 2006 Supervisor – Matthew Hicks (Research Assistant – PhD candidate),


Winter 1999 Supervisor – Clare Hildebrandt (Research Assistant – Masters student),


Summer 1999 Supervisor – Christina Melton (Research Assistant - Masters prepared),


1996 – 1997 Supervisor – Sheril Desjardins-Denault (Research Assistant – Masters

prepared), Clinical Epidemiology Unit – SCO Hospital Élisabeth-Bruyère

Pavilion, Ottawa ON.


VI. ADMINISTRATIVE RESPONSIBILITIES

(i) Departmental / School

Member School of Pharmacy, Graduate Studies & Research Committee, Sept 2014 -

present.

Co-Chair School of Pharmacy, Research Seminar Committee, Sept 2014 - present.

Member School of Pharmacy, Assessment Committee, Aug 2012 –

Member School of Pharmacy, Tenure & Promotion Committee, April 2017 - ;May 2015-

2016; Sept 2014-2015; Aug 2012 – 2013.

Member Co-Chair, Program Planning Committee, 4th Annual Canadian Pharmacy,

Education & Research Conference and 70th Annual General Meeting of the

Association of Faculties of Pharmacy of Canada, Niagara-on-the-Lake, ON, June

11-13, 2013.

Member School of Pharmacy, Recruitment Selection Committee (Librarian), April 2012

Member School of Pharmacy, School Advisory Committee on Appointments (SACA),

Sept 2011 - present

Member Executive committee member – Calgary Institute for Population & Public Health

(CIPPH), University of Calgary, Sept 2010 – June 2011.

Member Program Planning Committee, 2007 Conference of Canadian Society for

Epidemiology & Biostatistics (CSEB), Calgary, AB, May28-31, 2007.

Member Graduate Education Committee Neutral Chair Working Committee, Oct 2007 –

2009; Jan 2010 – June 2011.

Member Graduate Education Committee (alternative faculty member as of May, 2004-

Sept 2006)

Member Epidemiology and Biostatistics Cluster / Journal Club

Member Supervisory & Teaching Committee, Department of Community Health Sciences,


Co-Chair Graduate Student Research Day (January 1999), Department of Community

Health Sciences, University of Calgary

Member Organizing Committee, Canadian Society for Epidemiology & Biostatistics

Student Meeting, Nov 20-21, 1998

(ii) Faculty

Member Faculty of Science, Representative for School of Pharmacy (Feb 2017 – present)

Member HeForShe Faculty of Science Committee, University of Waterloo (Dec 2015 –

present)

Member Tenure and Promotion Committee, Faculty of Science, University of Waterloo

(June 2013 - 2014)

Member Conjoint Health Research Ethics Board (Oct 2006-Jan 2008)

Member Residency Committee in Geriatric Medicine, Faculty of Medicine, University of

Calgary

Member Division of Geriatric Medicine, Faculty of Medicine, University of Calgary

Member Strategic Advisory Committee – Elder Friendly Communities Project, Faculty of

Social Work, University of Calgary

Member Health Research Group, Faculty of Medicine, University of Calgary

Member Academic Selection Committee – Geriatric Medicine, Faculty of Medicine,


Member Academic Selection Committee – Epidemiologist (Joint Injury & Arthritis

Research Group), Faculty of Medicine, University of Calgary

(iii) University

Member Board Member, Propel Centre for Population Health Impact, University of


Waterloo (July 2013 – present).

Member Member, Survey Research Centre, University of Waterloo (March 2012 –

present).

Member Research Development and Policy Committee (Faculty of Medicine

Representative, Aug 2006- June 2010).

Member University Research Grants Committee (June 2010 – 2011).

(iv) Regional Health Authority

Member Conjoint Scientific Review Committee (Health Care Research Section), Centre

for Advancement of Health, Foothills Hospital, Calgary Regional Health

Authority (Mar 1998 - Jan 2002).

Member Clinical Trials Review Committee, Centre for Advancement of Health, Foothills

Hospital, Calgary Health Region (Jan 2002 – Nov 2007).

VII. PROFESSIONAL ACTIVITIES

(i) Membership in Professional and Learned Societies

June 2013 – present Board Member, Canadian Society for Epidemiology and Biostatistics

(CSEB).

Aug 2009 – 2012 Board Member & Academic North America Representative, International

Society for Pharmacoepidemiology (ISPE) http://www.pharmacoepi.org/

Nov 2005 – Nov 2009 Member, Health Technology Assessment International (HTAi)

July 2003 – present Member, Gerontological Society of America

July 2003 – present Member, International Society for Quality of Life Research (ISOQOL)

June 1999 – present Member, International Society for Pharmacoepidemiology (ISPE)

April 1998 – present Member, Canadian Association for Population Therapeutics (CAPT)

May 2000 – present Board Member, Canadian Association for Population Therapeutics

June 2004 – present Past-President, Canadian Association for Population Therapeutics

April 2003 – May 2004 President, Canadian Association for Population Therapeutics

Dec 1998 – present Member, Canadian Society for Epidemiology and Biostatistics (CSEB)

Nov 1991 – Jan 1995 Member, Canadian Society for Epidemiology and Biostatistics

Aug 1990 – 2000 Member, Canadian Association on Gerontology (CAG)

Jan 1990 – Jan 1995 Member, Ontario Gerontology Association

(ii) Professional Service

April 2017 – present Member, Expert Advisory Group, CIHI Dementia Project.

Jan 2017 – present Member, Expert Advisory Group, CIHI Frailty Project.

June 2013 – present Researcher, Health System Performance Research Network, OMHLTC

Sept 2010 – present Member, Canadian Chronic Disease Surveillance System for Neurological

Conditions (CCDSS-NC) Working Group, Public Health Agency of

Canada

Feb 2010 – July 2012 Member, CIHI Home & Continuing Care Advisory Committee.

Jan 2010 – present Member/Research Consultant, Cognitive Neuroscience Clinic, Alberta

Health Services - Calgary Zone. The design, implementation and analysis

of a prospective patient registry.

June 2010 Mentor, CIHR-IA / Alberta Centre on Aging: Summer Program in Aging

(June 13-17, 2010, Jasper Park Lodge, Alberta)


Feb 2009 – present Member, Ontario Home Care Research & Knowledge Exchange Network

in Chronic Disease Management.

Nov 2008 – 2010 Member, Health Canada Progressive Licensing Framework (PLF) Advisory

Committee.

Oct 2008 – June 2011 Member and Research Advisor, Quality Improvement and Measurement

Project Core Task Team - Alberta Health Services.

Oct 2008 – 2011 Member & Research Consultant, Alberta Health & Wellness, Health

Informatics Planning Committee.

Aug 2008 – 2011 Member, Expert Advisory Committee - Alberta Osteoporosis Project.

June 2008 – present Member, CIHI-RAI Medication Committee

2007 – 2010 Member & Research Consultant, CAN-STRIVE (Canadian Staff Time &

Resource Intensity Verification) Project – ON Ministry of Health & Long

Term Care.

2006 – Jan 2008 Board Member, Calgary Seniors’ Resource Society.

2004 – 2005 Chair, Annual Meeting of the Canadian RAI Research Group, Canadian

Collaborating Centre for interRAI, March 12-14, 2005, Banff AB.

Dec 2004 – 2007 Member, AH&W Data Access & Research Advisory Committee

Nov 2004 – present Research Consultant, Canadian Hypertension Education Program –

Outcomes Research Task Force, Public Health Agency of Canada.

Sept 2004 – present Member, Genesis ICE Research Team, Gender Issues in Cardiovascular

Disease, Treatment & Management.

Sept 2004 – Mar 2008 Member, Capital Care Group CHSRF Knowledge Brokering Workgroup

Jan 2004 – 2007 Member, Continuing Care Systems Project (CCSP).

Dec 2003 – present Member, Canadian Institute for Health Information (CIHI) ~ Resident

Assessment Instrument (RAI) Expert Panel.

Oct 2003 – present Clinical Subgroup Lead Investigator (Medications) ~ Canadian

Longitudinal Study of Aging CIHR Initiative.

Dec 12, 2002 Member, Pharmaceutical Information Network Research Workgroup,

Alberta Wel//net, Edmonton AB

July 16, 2002 Academic Lecturer – Shad Valley International Summer Learning Program

for Outstanding High School Students, University of Calgary

Jan 2001 – 2003 Member, Continuing Care Information & Accountability (CCIA) Business

Resource Working Group, Alberta Health & Wellness, Edmonton AB

June 19, 2001 Participant - Focus Group Review of the Institute of Healthy Aging

(CIHR), Vancouver BC.

2000 – 2001 Chair, Local Organizing Committee, 2001 Annual Conference of the

Canadian Association for Population Therapeutics (CAPT), Banff AB

Oct 1999 – present Member, Research Advisory Panel of the Canadian Collaborating Centre

for interRAI.

Oct 1999 – 2002 Member, Workgroup on Quality Indicators for Home Care, RAI Health

Informatics Project, University of Waterloo & Canadian Collaborating

Centre - interRAI

May 1999 – 2001 Member, Alberta Mental Health Board Technical Advisory Committee –

Standardized Client Satisfaction Measures Pilot Study

Jan 1999 – 2003 Primary Investigator, Canadian Study of Health and Aging (CSHA-2 &

CSHA-3), Calgary Site

Jan 1996 – 2006 Research consultant, Cancer Division, Health Canada.

Dec 1996 – 2000 Member, Joint Policy & Planning Committee (Ontario Ministry of

Health/Ontario Hospital Association) Psychiatric Working Group for

RAI/MDS-Mental Health

June 1996 – Sept 1997 Director, Older Women’s Health Research Group, SCO Hospital Élisabeth-

Bruyère Pavilion

Jan 1996 – Sept 1997 Co-Investigator, Canadian Study of Health and Aging (CSHA-2), Ottawa-

Carleton Site


Jan 1996 – Sept 1997 Chair Utilization Management Committee, SCO Hospital Élisabeth-

Bruyère Pavilion

Sept 1995 – Sept 1997 Member, Research Ethics Board, SCO Hospital Élisabeth-Bruyère Pavilion

Journal Review

Annals of Internal Medicine; British Journal of Clinical Pharmacology; British Medical Journal; BMC

Geriatrics; BMC Medicine; BMC Women’s Health; Canadian Journal on Aging; Canadian Journal of

Cardiology; Canadian Journal of Clinical Pharmacology; Canadian Journal of Public Health;

Canadian Medical Association Journal; Geriatrics Today: Journal of the Canadian Geriatrics Society;

Healthcare Management Forum; Healthcare Policy; International Journal of Geriatric Psychiatry;

International Psychogeriatrics; Irish Journal of Medical Science; Journal of Alzheimer’s Disease;

Journal of the American Geriatrics Society; Journal of Gerontology: Medical Sciences; Journal of

General Internal Medicine; Journal of Health Care for the Poor and Underserved; Journal of

Population Therapeutics and Clinical Pharmacology; Quality of Life Research; Medical Care;

Neurology; Pharmacoepidemiology and Drug Safety; Preventive Medicine; Scandinavian Journal of

Public Health; Stroke.

Abstract Review

Canadian Society for Epidemiology & Biostatistics; Canadian Association for Population

Therapeutics; International Society for Pharmacoepidemiology; International Conference on

Pharmacoepidemiology and Therapeutic Risk Management; International Association of Gerontology.

Editorial Board Jan 2014 – present Associate Editor, Canadian Geriatrics Journal

Nov 2007 – present Member, Editorial Board, Canadian Journal of Cardiology

May 2004 – present Associate Editor, Journal of Population Therapeutics and Clinical

Pharmacology (formerly Canadian Journal of Clinical Pharmacology)

Jan 2003 – 2006 Member, Peer Review Committee, STRIDE: Excellence in Seniors Care

Grant / Scholar Review

Retired Teachers of Ontario (RTO) Grant Review, April 2017-March 2018

CIHR Cluster Chair, Project Grant, Oct 2016 – May 2017

Reviewer, CIHR Gold Leaf Awards, Sept – Dec, 2016.

External Reviewer, Tenure & Promotion Application, Memorial University, Nov 2016

External Reviewer, PSI Foundation, May 2016

External Reviewer, United States – Israel Binational Science Foundation, March 2016

Michael Smith Foundation For Health Research (MSFHR) Scholar Program, February 2016

External Reviewer, TVN 2015 Transformative Grant Program, January 2016

External Reviewer, Tenure & Promotion Application, University of Calgary, 2015

External Reviewer, CIHR CRC Chair, Dec 2015.

CIHR HS1 Committee – Chair, June 2015.

CIHR Foundation Grant Stage I – Chair, Sept – Dec, 2014.

External Reviewer, Tenure & Promotion Application, Huntington University, Nov 2014.

Propel Centre for Population Health Impact, University of Waterloo, Chronic Disease Prevention

Initiative - Seed Grants, June 2014.

M.S.I. Foundation, Operational Grants, Alberta, April-May, 2012.

CIHR-Health Services Evaluation & Interventions Research 2 Peer Review Committee

(operational grants), May 2014, Nov 2013, May 2013, Nov 2012, Nov 2011 and ongoing

member.

External Reviewer, Tenure & Promotion Application, University of Toronto, Departments of

Medicine and Health Policy, Management & Evaluation, June 2012.

External Reviewer, Canada Research Chair Tier 1, Aug 2010.


CIHR Operating Grant: Prevention of Cardiovascular & Respiratory Diseases Committee

Member, Sept 2009.

External Reviewer, Ontario Ministry of Health and Long-Term Care, Career Scientist Award,

May 2009.

Canadian Stroke Network and Heart & Stroke Foundation of Canada – Vascular Cognitive

Impairment Research Initiative, Dec 2008.

External Reviewer, Tenure & Promotion Application, University of Toronto, Department of

Health Policy Management & Evaluation, Dec 2008.

CIHR-IHSPR Seed Grant: Knowledge Exchange in Health Services & Policy Research, Feb

2008.

External Reviewer, Petro-Canada Young Innovator Award (ON), May 2007.

External Reviewer, Ontario Ministry of Health and Long-Term Care, Career Scientist Award,

April 2007.

CIHR-Institute of Aging Pilot Projects Committee, Dec 2006.

External Reviewer, Tenure & Promotion Application, University of Manitoba, Faculty of

Pharmacy & Dept. of Community Health Sciences, Aug 2006.

CIHR – Scoping Reviews & Research Syntheses Priority Health Services & Systems, Oct 2005.

Heart & Stroke Foundation of Canada (in collaboration with CIHR & Alzheimer Society of

Canada - Vascular Dementia Strategic Initiative Internal Review Committee), March 2004.

Heart & Stroke Foundation of Canada, External Reviewer, Nov 2006; Nov 2004; Nov 2003.

Alberta Heritage Foundation for Medical Research (AHFMR), Health Trainee Awards Sept 2002

– Sept 2005.

Alberta Heritage Foundation for Medical Research (AHFMR), Community Health Research

Travel Grant: Jan 2002 – 2003.

Provincial Health Services Utilization Committee (Chair – Bonnie Laing, Calgary AB) – Nov

2001.

Research Coordinating Committee (RCC) – Institute of Health Economics: May 2001 – 2010.

CIHR/SSHRC/NHRDP Health Career Award (Investigator Award) - June, 2000.


VIII. RESEARCH SUPPORT

2017-18 Tyas SL, Maxwell CJ, Iraniparast (Co-PIs). Predictors of cognitive state

trajectories in longitudinal studies of aging. Network on Aging Research (NAR)

Catalyst Grant Competition, University of Waterloo ($19,979.70).

2017-18 Oremus M, Maxwell CJ, Tyas S, Konnert C, Law J, Tuokko H. The association

between social support, depression and cognition in mid-to late-life: A cross-

sectional analysis of the Canadian Longitudinal Study on Aging. CIHR Catalyst

Grant: Analysis of CLSA Data ($69,972).

2017-19 Rotstein D, Marrie RA, Tu K, Tu J, Maxwell C. Immigration and the risk of

Multiple Sclerosis. Multiple Sclerosis Society of Canada Operating Research

Grant, $102,774.64.

2016-17 Rotstein D, Marrie RA, Tu K, Tu J, Maxwell C. Immigration and risk of MS.

Consortium of Multiple Sclerosis Centers (CMSC), Pilot Grant, $39,880.50 US.

2016-21 Anderson G, Rockwood K, Hogan DB, St. George-Hyslop P, Naylor D, Menec

V, Costa A, Herrmann N, Maxwell CJ. Broad and Deep Analyses in

Neurodegeneration (BRAIN): Projects 4 & 6. CIHR ($945,000).

2015-16 Middleton L, Giangregorio L, Heckman G, Maxwell C, Hobson N, Tyas S,

Regan K. Getting older adults with MCI and dementia active: what do we need?

University of Waterloo, Chronic Disease Prevention Initiative Seed Grant -

PROPEL Centre for Population Health Impact ($10,000).

2015-16 Bell CM, Bronskill SE, Gruneir A, Rochon PA (Co-PIs); Austin PC, Farrell B,

Gill SS, Herrmann N, Jeffs L, de Lemos J, Lix L, Maxwell CJ, McCarthy L,

Metge C, Seitz DP, Wodchis WP (Co-Investigators) and team. Team Grant in

Late Life Issues: Optimizing prescribing in late life for women and men. CIHR

Phase 1: Letter of Intent, ($24,945).

2015-16 Seitz D, and team (including Maxwell CJ). A systematic review and meta-

analysis of the accuracy of depression rating scales to diagnose depression in

older adults with Alzheimer’s disease and other dementias. CIHR Knowledge

Synthesis Grant, ($100,000).

2015-18 Banwell B, Marrie RA, Bar-Or A, Arnold D, Yeh A, with co-investigators across

Canada, including Maxwell CJ. Progressive degeneration from onset in pediatric

multiple sclerosis: Evaluation of clinical and health-related quality of life, early

loss of brain integrity and accelerated immune senescence. Multiple Sclerosis

Scientific Research Foundation ($3,263,384.63).

2014-17 Morris A, Bell C, Bronskill S, Jeffs L, Maxwell CJ (Co-PIs), Co-Investigators:

Amuah J, Daneman N, Gill S, Gruneir A, Hogan D, Hyland S, Law M, Loeb M,

Mitchell J, Moore K, Patten S, Powis J, Ricciuto D, Sinha S, Seitz D, Teare G,

Thavorn K, Wodchis W. FRAMING-LTC: Frailty and Recognizing Appropriate

Medications IN Geriatrics and Long-Term Care. TVN Strategic Impact Grant,

($596,906).

2014-17 Maxwell CJ, Bronskill SE (Co-PIs), Austin P, Gill S, Gruneir A, Hogan D, Patten

S, Seitz D, Teare GF, Thavorn K, Wodchis W. Exploring frailty and its role in the

assessment of high risk medications and risk for poor health outcomes in


vulnerable populations. Canadian Institutes of Health Research (CIHR),

($330,803).

2014-17 Tyas SL, Maxwell CJ, Riley K, Santacruz K, St. John P, Zeng L. Early-life

factors and later-life cognitive resilience: linking evidence across a lifetime.

Canadian Institutes of Health Research (CIHR), ($180,000)

2014-19 Herrmann N, Lanctôt KL, Seitz D, (Team Leaders), with co-investigators

including Maxwell CJ. Prevention and treatment of neuropsychiatric symptoms

(CCNA Team 11). Canadian Institute of Health Research and Partners for the

Canadian Consortium on Neurodegeneration in Aging (CCNA), ($1,011,616).

2014-16 Guthrie DM, Reid C, Maxwell CJ, Mitchell L. The development of a screening

tool for caregiver burden in home care. Alzheimer Society Research Program,

($119,998).

2014-15 Maxwell CJ, Bronskill SE (Co-PIs), Austin P, Gill S, Gruneir A, Hogan D, Patten

S, Seitz D, Teare G, Wodchis W. Exploring frailty and its role in the assessment

of high risk medications and risk for poor health outcomes in vulnerable

populations. CIHR-Drug Safety and Effectiveness Bridge Funding ($100,000).

2013-16 Wodchis, Walter P (PI). Collaborators: Anderson, Geoff M.; Baker, G. Ross;

Barnsley, Janet; Berta, Whitney; Bierman, Arlene; Bronskill, Susan E.; Cohen,

Eyal; Cott, Cheryl; Durbin, Janet; Gruneir, Andrea; Guttmann, Astrid; Kone

Pefoyo, Anna J.; Kuluski, Kerry H.; Laporte, Audrey; Lin, Elzabeth; Lum, Janet;

Maxwell, Colleen J.; Manuel, Douglas; McKillop, Ian; Morisano, Dominique;

Tanuseputro, Peter; Lyons, Renee; Ungar, Wendy; Williams, A. Paul. Health

System Performance Research Network. Ontario Ministry of Health and Long-

Term Care. Health System Research Fund.. $4,645,109 CAD.

2013-14 Maxwell CJ, Bagshaw S, Bronskill S, Hemmelgarn B, Hogan D. Emerging

research and clinical priorities in the detection and management of frailty in older

patients across acute care settings. CIHR Planning Grant, Health Services and

Systems for an Aging Population ($24,150).

2013-14 Grindrod K, Burns C, Baskerville B, Chang F, Giangregorio L, Maxwell CJ,

Middleton L, Penny Light T, Tomasson Goodwin J. Building an interdisciplinary

team to research mobile health applications for older adults. University of

Waterloo, PROPEL Centre for Population Health Impact ($10,000).

2013-15 Seitz D, Maxwell CJ, Gill S, Vigod S, Blumberger D, Brander R. Effects of a

volunteer ‘friendly visitor’ program on depressive symptoms among home bound

older adults who live alone. Clinical Teachers’ Association at Queen’s

Endowment Fund ($20,000).

2011-13 Korngut L, Jetté N, Pringsheim T (Co-PIs), Maxwell CJ, et al. Neurological

Registry Best Practice Guidelines and Implementation Toolkit. Public Health

Agency of Canada ~ National Population Health Study of Neurological

Conditions ($209,496).

2010-13 Hirdes JP, Maxwell CJ, Jetté N (Co-PIs), Berg K, Bronskill SE, Clarke B,

Colantonio A, Doran D, Heckman G, Hogan D, Kergoat M-J, Marrie R-A, Martin

L, Mitchell L, Postuma R, Pringsheim T, Zygun D. Innovations in Data, Evidence

and Applications (IDEAs) for Persons with Neurological Conditions. Public


Health Agency of Canada ~ National Population Health Study of Neurological

Conditions ($1,477,342).

2010-13 Jetté N & Pringsheim T (Co-PIs), Maxwell CJ et al. Understanding the

epidemiology of neurological conditions and building the methodological

foundation for surveillance. Public Health Agency of Canada ~ National

Population Health Study of Neurological Conditions ($402,000).

2009-13 Maxwell CJ (PI), Academic Team: Strain LA, Hogan DB, Patten SB, Hagen B,

Sales AE, Gruneir A; Decision/Policy Maker Team: Le Clair K, Wilson K,

Stelmachovich D, Grabusic C, West B, Schalm C, Andison EA, Dharma-

Wardene M, Berry B, Zieber C. Enhancing system capacity to improve the

quality and continuity of mental health care for seniors in assisted living and

long-term care. Alberta Mental Health Research Partnership Program –

Collaborative Research Grant Initiative: Mental Wellness in Seniors and Persons

with Disabilities ($210,000).

2010-12 Marshall DA (PI), Co-Investigators: C. Frank, T. Noseworthy, P. Rogers, T.

Rohleder, M. Carter, C. Maxwell, D. Mosher, S. Vanderby. A Decision Support

(SD) Tool for Planning Integrated Sustainable Health Services for Patient with

Osteoarthritis of the Hip and Knee. CIHR/Arthritis Society Award #: 225650

($240,000 ) Description: This study will develop an evidence based decision

support tool for planning future health care resource needs within a sustainable

system of care for hip and knee osteoarthritis.

2009-10 Dalby DM, Hirdes JP, Stolee P, Fletcher PC, Papaioannou A, Maxwell CJ, Poss

J, Berg KO. Enhancing the use of standardized assessment data for quality

improvement in home care. CIHR Catalyst Grant ($49,778).

2009-10 Dalby DM, Reid C, Broemeling A, Maxwell CJ, Archibald K. Effective use of

RAI data for informed decision-making and improved home health services

quality. CIHR Meetings, Partnerships and Dissemination Grants ($14,900).

2008-10 Sales A, Schalm C, Andison E, Debruyn J, Duebel T, Gowriluk B, Maisey S,

Mansell L, Maxwell CJ, Teare GF, Wilkinson B. Putting RAI to work: Network

of RAI data users and researchers. CIHR Knowledge to Action Competition.

($199,985).

2008-12 Sales A, Schalm C, Maisey S, Milke D, Thompson E, Neumann I, Anderson M,

Lai V, Maxwell CJ, Liu L, Warren S, Estabrooks C, Mansell L, Elliott K. Data

for Improvement and Clinical Excellence (DICE) Program. CHSRF – Research,

Exchange, and Impact for System Support (REISS) Competition. ($796,890 co-

funded by CHSRF and AHFMR).

2008-09 Maxwell CJ (PI), Hogan DB, Supina AL, Amuah JE, Hirdes JP, Jantzi M, Poss, J,

Wodchis W, Lynd L, Marra C. “Economic Evaluation of Therapies for

Alzheimer’s Patients in Alberta & Canada” ($48,784) - Brenda Strafford

Foundation Chair in Geriatric Medicine.

2007-08 Sales A, Maxwell CJ, Teare G. “Pilot Project: Prioritizing process improvement

indicators using RAI data” ($47,000) – CHSRF (Knowledge Brokering Group,

CapitalCare).


2007-10 Hirdes JP (PI), Fries BE, Poss J, Smith TF, Maxwell CJ. “Canadian Staff Time

and Resource Intensity Verification: CAN-STRIVE” ($2,248,231) – Ontario

Ministry of Health and Long Term Care.

2006-09 Maxwell CJ (PI), Hogan DB, Strain LA, Hepple R, Schmaltz H, Yong VW,

Patten SB, Parboosingh JS, Rolfson D, Eliasziw M. “Frailty, Inflammatory

Mechanisms and Adverse Health Outcomes among Vulnerable Seniors”

($177,042) – CIHR.

2005-08 Maxwell CJ & Strain L (Co-PIs), Hogan DB, Teare G, Eliasziw M, Parboosingh

J, Hagen B, Zimmerman D, on behalf of the CCIC Research Consortium.

“Continuing Care Reform: Implications for the Balance and Quality of Care for

Frail Older Canadians” ($900,000) – AHFMR Programs in Health Services

Research.

2005-06 Maxwell CJ & Teare G (Co-PIs), Hogan DB, Lewis SJ, Walker JD. “Potentially

Avoidable Hospitalization of Institutionalized Older Persons” ($100,560) –

CIHR.

2005-06 Maxwell CJ (PI), Hogan DB, Ghali WA, Parboosingh JS, Schmaltz H, Knudtson

M, Anderson T, Galbraith D, Faris P, Maitland A. “Frailty, Inflammatory

Mechanisms and Adverse Health Outcomes among Older Patients” ($50,000),

Brenda Strafford Foundation Chair in Geriatric Medicine.

2005-06 Maxwell CJ (PI), Hogan DB, Currie G, Eliasziw M, Silvius JL, Supina A.

“Demographic and Clinical Characteristics Associated with Donepezil

(Aricept™) and Rivastigmine (Exelon™) Use in Saskatchewan”, ($54,260),

Institute of Health Economics.

2005 Maxwell CJ (PI), Eliasziw M, Zhang J. “Prevalence and Treatment of

Hypertension and Health Outcomes among Canadians: Regional & Time Trends”

(9,945), Public Health Agency of Canada.

2004-06 Maxwell CJ (PI), Hogan DB, Parboosingh JS, Ghali WA, Anderson TJ, Faris P,

Galbraith D, Knudtson ML, Patten SB, Maitland A, Demchuk A, Shewchuk L.

“Homocysteine, Folic Acid and Vascular Outcomes among Older Cardiac

Patients”, ($50,000), Brenda Strafford Foundation Chair in Geriatric Medicine.

2004-05 Lewis S (PI), Dunn J, Ghali W, Maxwell CJ, Noseworthy T. “Americans’

Experience of Two Health Care Systems”, ($28,050), Max Bell Foundation.

2004-06 Maxwell CJ (PI), Anderson T, Parboosingh J, Hogan DB, Ghali W, Faris P,

Galbraith D, Knudtson M, Shewchuk L, Patten SB. “Homocysteine, Folic Acid

and Vascular Outcomes among Elderly Cardiac Patients: Exploring Relevant

Gene-Environment Interactions”, ($49,860) – M.S.I. Foundation.

2004-06 Maxwell CJ, Victorino CC (Co-PIs), Hogan DB, Patten SB, Fisher K. “The

Prevalence and Pharmacological Management of Pain among Older Persons

across Care Settings”, ($115,580.00) – Institute of Health Economics.

2004-05 Wolfson C, Kirkland S, Raina P (Co-PIs), and the CLSA Co-Investigator Team

(too numerous to list, includes Maxwell CJ). “The Canadian Longitudinal Study

of Aging: Developmental Activities – Phase I”, ($1,744,000) – CIHR.


2003-05 Ghali WA, Galbraith D (Co-PIs), Svenson L, Maxwell CJ, Schopflocher D,

Knudtson M, Larsen E. “Health Surveillance for Acute Myocardial Infarction in

Canada: A Comparison of Administrative and Laboratory Data Case

Definitions”, (year 1 $36,000 / year 2 $46,000) – Health Research Fund,

AHFMR.

2003-07 Maxwell CJ (PI), Hogan DB, Ghali W, Faris P, Galbraith D, Knudtson ML,

Patten S, Maitland A, Demchuk A, Parboosingh J, Jelinski S. “The Impact of

Neurocognitive and Psychological Factors on Quality of Life and Functional

Recovery among Older Patients Undergoing Coronary Revascularization

Procedures”, ($204,819) – CIHR-Institute of Aging.

2003-04 Patten SB, Wang JL, Currie SR, Maxwell CJ, El-Guebaly N. “Descriptive

epidemiology of major depression in the Canadian population”, ($39,299) –

CIHR.

2003 Menon D, Feeny DH, Jacobs P, Johnson JA, Majumdar S, McAlister F,

Maxwell CJ, Tsuyuki RT. The Merck Company Foundation Program on

Pharmaceutical Policy Issues. Centre of Excellence in Health and Pharmaceutical

Outcomes, Policy and Economics Research – Institute of Health Economics

(US $100,000)


Patten S, Maitland A, Demchuk A. “Coronary Revascularization and

Neurocognitive Outcomes among Older Patients with Ischemic Heart Disease: A

Pilot Study”, ($70,000/2 years) - MSI Foundation, August 2002.


Patten S, Maitland A, Demchuk A. The Impact of Neurocognitive and

Psychological Factors on Quality of Life and Functional Recovery among Older

Patients Undergoing Coronary Revascularization Procedures”, ($50,000) –

Research Allowance, CIHR-Institute of Aging New Investigator Award.

2002-03 Maxwell CJ (PI), Jelinski SE, Hogan DB, Silvius JL, Campbell NRC.

“Prevalence, Correlates and Health Consequences of Donepezil (Aricept) Use in

Alberta: Implications for Cost-Effectiveness Estimates”, ($30,000) – Special

Alzheimer Research Funding Competition, Calgary Health Region.

2002 Maxwell CJ (PI), Jelinski SE. “An Examination of the Initiation and Maintenance

of Breast Cancer Screening Behaviours in Canadian Women: Findings from the

NPHS Longitudinal Panel”, ($10,000) – Cancer Division, Health Canada.

2002 Maxwell CJ (PI), Jelinski SE. “An Examination of the Associations between

Clinical Breast Examination and Breast Self-Examination and Mammography

Participation among Canadian Women: Findings from the 1996-97 and 1998-99

NPHS Longitudinal Panel”, ($10,000) – Cancer Division, Health Canada.

2002 Maxwell CJ (PI), Jelinski SE. “A Comparison of Mammography Screening

Intentions and Behaviours among Canadian Women: Findings from the 1996-97

and 1998-99 NPHS Longitudinal Panel”, ($10,000) – Cancer Division, Health

Canada.

2001 – 2002 Maxwell CJ (PI), Wodchis WP, Hogan DB, Feeny DH, Donaldson C, Zhang JX,

Wright B. “Measuring Health Related Quality of Life in the Frail Community-

Based Elderly”, ($46,992) - Institute of Health Economics, July 2001.


2001 – 2003 Ghali WA (PI), Maxwell CJ, Donaldson C, Knudtson ML, Lewis SJ, Faris P, Tu

JV. “Access to Urgent Technology Care for Acute Myocardial Infarction”,

($27,578: year 1-$15,146 / year 2- $12,432) – Institute of Health Economics,

March, 2001.

2001 – 2003 Ghali WA (PI), Tu JV, Donaldson C, Lewis SJ, Faris P, Maxwell CJ, Knudtson

ML. “Highly Centralized Tertiary Care Services and Access to Urgent High

Technology Care for Acute Myocardial Infarction”, ($131,000: year 1-$72,000 /

year 2-$59,000) – CIHR Operating Grant, January 2001.

2000 – 2002 Menon D, Donaldson C, Farris KB, Feeny DH, Jacobs P, Johnson JA,

Maxwell CJ, Topfer LA, Tsuyuki RT. The Merck Company Foundation Program

on Pharmaceutical Policy Issues. Centre of Excellence in Health and

Pharmaceutical Outcomes, Policy and Economics Research – Institute of Health

Economics (US $200,000 annually)

2000 – 2003 Maxwell CJ (PI), Hogan DB, Ikuta R, Hirdes JP. “A randomized trial of an

integrated assessment and care plan approach for home care among post-acute

elderly sample”, ($242,000) – PHI Establishment Grant, Alberta Heritage

Foundation for Medical Research.

2000 – 2002 McDowell IW and Canadian Study of Health & Aging Workgroup (Maxwell CJ-

PI for Calgary Site). “Understanding cognitive decline: Patterns and prognosis. A

final follow-up to the Canadian Study of Health and Aging (CSHA-3)”

($3,502,324 Total / $130,040 Calgary Centre) – CIHR Operating Grant, July

2000.

2000-2002 Maxwell CJ (PI), Hogan DB, Silvius JL, Campbell NRC. “Demographic and

clinical characteristics associated with donepezil (Aricept) use in Alberta”

($32,375) – Institute of Health Economics, August 2000.

2000-2002 Menon D, Donaldson C, Farris KB, Feeny DH, Jacobs P, Johnson JA, Maxwell

CJ, Topfer LA, Tsuyuki RT. The Merck Company Foundation Program on

Pharmaceutical Policy Issues. Centre of Excellence in Health and Pharmaceutical

Outcomes, Policy and Economics Research – Institute of Health Economics (US

$200,000 annually).

2000-2001 Maxwell CJ (PI), Vik SA, Hogan DB, Patten SB, Johnson JA, Romonko-Slack L.

“Drug Compliance and Health Outcomes in the Community-Dwelling Elderly: A

Comparison of Urban and Rural Home Care Clients”, ($96,030.10) – Institute of

Health Economics (Grant from The Merck Company Foundation Program on

Pharmaceutical Policy Issues).

2000 Maxwell CJ (PI). “Cross-sectional Examination of Breast and Cervical Cancer

Screening Behaviours and Associated Factors in Canadian Women: Findings

from the 1996-97 NPHS”, ($9,625) – LCDC, Health Canada.

1999-2001 Maxwell CJ (PI), Hogan DB, Ebly EM, Bland R (Co-Invs). “Health Care

Utilization for Alberta Participants in the Canadian Study of Health and Aging

(CSHA)”, ($20,000) – Special Research Funding Competition on Alzheimer’s

disease, CAH, Calgary Regional Health Authority.

1998-2001 Hirdes JP (PI), Challis G, Fletcher P, Frijters D, Maxwell CJ, Perez E, Smith T,

Stones M, Strain L, Teare G, Tjam E. “Resident Assessment Instrument-Health


Informatics Project (RAI-HIP)” ($1.67 million) – Health Transition Fund, Health

Canada.

1999-2001 Maxwell CJ (PI), Ghali W (Co-Inv). “The Influence of Sociodemographic and

Ethnic Factors on In-Hospital Treatment and Management of Myocardial

Infarction: Implications for Quality of Care”, ($20,000) – Special Grant

Competition, CAH, Calgary Regional Health Authority.

1999 Maxwell CJ. (PI). “A Longitudinal Examination of Breast and Cervical Cancer

Screening Behaviours and Associated Factors in Canadian Women: Findings

from the NPHS”, ($9,992) – LCDC, Health Canada.

1999 Maxwell CJ. (PI). “Factors Important in Promoting Proactive Breast and Cervical

Cancer Screening Behaviours in Canadian Women: Comparison of Findings from

1994-95 and 1996-97 NPHS”, ($10,000) – LCDC, Health Canada.

1999-2000 Russell M (PI), Patten S (PI), Thurston W, Casebeer A, Vollman A, Maxwell CJ

(Co-Invs). “Client Satisfaction and Health Behaviour Survey”, ($36,000) –

Headwaters Health Authority: Strategies, Communications Research.

1998-1999 Church DL (PI), Davies D, Louie T, Donaldson C, Maxwell CJ, Mitton C (Co-

Invs). “Clinical and Economic Evaluation of Rapid Diagnostic Virology Service

for Influenza A: A Pilot Project”, ($47,350) – Calgary Laboratory Services:

Health Services Research Fund.

1998 Maxwell CJ (PI), Hogan DB, Cohen A (Co-Invs). “Validity of Drug Data for

Geriatric Pharmacoepidemiology: A Pilot Study of Elderly Outpatients”, ($5,000)

– Foothills Hospital Research & Development Committee, Centre for

Advancement of Health, Calgary Regional Health Authority.

1995-1997 Hirdes JP, Maxwell CJ (Co-PIs). “A Multimedia Health Promotion Program on

Women, Smoking, and Health”, ($125,000) – Community Tobacco Initiative,

Health Canada.

1996 Maxwell CJ (PI), Kozak JF (Co-Inv). “Factors Important in Promoting Proactive

Breast and Cervical Cancer Screening Behaviour in Community-dwelling

Women”, ($29,485) – Disease Prevention Division, Health Canada.

1996-1997 Kozak JF (PI), Maxwell CJ (Co-Inv). “Canadian Study of Health and Aging

(CSHA) – 2, Ottawa-Carleton Site”, ($217,000) – National Health and Research

Development Program (NHRDP).

IX. INVITED ADDRESSES

Maxwell CJ. The Evolving State of Seniors Campuses. Ontario Association of Non-Profit Homes and

Services for Seniors (OANHSS) Member Forum, Invited Panel Member, Toronto, ON, April 20,

2017.

Maxwell CJ, Hogan DB, Strain L, Amuah JE. Role of frailty in understanding the risks and benefits of

pharmacotherapy in older adults. Invited Speaker, Evaluative Clinical Sciences Rounds, ICES,

Sunnybrook Health Sciences Centre, Toronto, ON, March 21, 2017.

Maxwell CJ. Assisted Living vs. LTC: Characteristics and Challenges/Opportunities for Research.

Invited Speaker, Pharmacotherapy in Older Adults with Cardiovascular Disease Workshop, American


College of Cardiology/American Geriatrics Society/National Institutes of Health, Washington, DC,

Feb 6-7, 2017.

Rockwood K, Maxwell CJ, Hogan DB. How to Identify Frailty. Frailty among the aged in Canada

Session, Health Research Caucus, Parliament Hill, Ottawa, ON, Oct 24, 2016.

Strain LA, Maxwell CJ, on behalf of the ACCES Research Group, Using RAI data: What did we learn

from ACCES? Invited panel presentation in session, “Using RAI Data to Improve Quality and Move

Toward Best Practice”, IQ2011: Inspiring Quality in Continuing Care, Edmonton, AB, Oct 2011.

Maxwell CJ, Strain LA, on behalf of the ACCES Research Group. Factors Predicting Discharge to

LTC among Residents in Alberta Assisted Living Facilities.

Invited Speaker, Alberta Continuing Care Association Board Meeting,

Calgary AB, December 7, 2010.

Maxwell CJ, Strain LA, Gilbart E. Case Mix in Assisted Living and Long Term Care in Alberta.

Invited Speaker, Alberta Health Services/CIHI/CHSRF - RUG Case Mix Knowledge Transfer Day.

Edmonton AB, Jan 12, 2010.

Maxwell CJ & Strain LA. Symposium on Assisted Living / Supportive Housing in Canada.

Invited Speaker, 2009 Canadian RAI Conference: Pulling it all together – Integrating health

information for planning, policy and practice.

Halifax NS, June 24, 2009.

Maxwell CJ & Strain LA. An Overview of Assisted Living in Canada and the ACCES Study.

Invited Speaker, Extendicare Western Canada Business Meeting,

Edmonton AB, Apr 23, 2009

Strain LA & Maxwell CJ. Designated Assisted Living in Alberta: Is this the new LTC?

Invited Speaker at the 8th Annual Long Term Care Colloquium,

Calgary AB, Feb 6, 2009.

Strain LA & Maxwell CJ. Assisted Living in Alberta: Research and Evidence from the ACCES Study.

Plenary Speaker at the Good Samaritan Society Conference: Assisted Living Above the 49th Parallel,

Banff AB, Oct 9, 2008.

Maxwell CJ. Assisted Living in Canada: Implications for the Quality of Care and Life for Seniors.

Plenary Speaker at the 2008 Registered Nurses Association of Ontario Elder Care Conference: Aging

and Health across the Continuum,

Toronto ON, Sept 25, 2008.

Maxwell CJ. Assisted Living in Alberta: Early findings from the ACCES study.

Invited Speaker, Alberta Continuing Care Association Board Meeting,

Edmonton AB, Sept 22, 2008.

Maxwell CJ (& Strain LA). Assisted Living in Alberta: Early lessons learned about residents’

clinical, psychosocial and quality of care needs from the ACCES Study.

Plenary Speaker at the 2008 Canadian RAI Conference: Making the Quality Connection – hosted by

Capital Health & interRAI,

Edmonton AB, May 29, 2008.

Maxwell CJ. Assisted Living in Alberta.

Invited Presentation – The 7th Annual Long Term Care Colloquium,

Calgary AB, Feb 2008.


Strain LA, Maxwell CJ. Challenges facing health services researchers: Examples from ACCES.

Presentation to the Knowledge Brokering Group,

Edmonton AB, June 2007.

Maxwell CJ. Assisted Living: Where Does (Should) it fit into the Continuum of Continuing Care?

CIHR-IA Sponsored Key Note Speaker – Annual Scientific Meeting of the Canadian Geriatrics

Society,

Banff AB, April 21, 2007.

Maxwell CJ. Where Does (Should) Assisted Living Fit into the Continuum of Continuing Care

Options for Older Albertans?

Presentation – The Greying Nation: transitions of care in later life – an international conference,

Edmonton AB, March 22, 2007.

Maxwell CJ (& Eldridge D). Realizing the Research and Policy Opportunities of RAI Data.

Presentation to the Capital Care Group – Knowledge Brokering Group “RAI Day: Translating

Information into Practice”

Edmonton AB, February 7, 2007.

Maxwell CJ (& Strain LA). Overview of the Alberta Continuing Care Epidemiologic Studies

(ACCES) Program.

Presentation to the Board – The Good Samaritan Society,

Edmonton AB, May 26, 2006.

Maxwell CJ (& Strain LA). Care and Quality of Life Needs of Seniors in Continuing Care: Review of

the Alberta Continuing Care Epidemiologic Studies (ACCES) Program.

Presentation to the Annual Meeting of the Alberta Long Term Care Association,

Calgary AB, November 8, 2005.

Maxwell CJ. Research Applications of RAI-HC Data.

Presentation to the Capital Care CHSRF Knowledge Brokering Demonstration Group, Capital Care

Group,

Edmonton AB, August 31, 2005.

Maxwell CJ. Alberta Experience with Quality Indicators.

Long Term Care Quality of Care ~ Workshop Presented by AH&W in partnership with the Regional

Health Authorities, Alberta Long Term Care Association & the Education Resource Centre for

Continuing Care,

Edmonton AB, September 15-16, 2004.

Maxwell CJ, Victorino CC, Hogan DB, Patten SB, Hirdes JP, Dalby DM. The Pharmacological

Management of Pain among Older Adults.

Institute of Health Economics – Annual Research Day,

Edmonton AB, June 11, 2004.

Maxwell CJ. Drug Related Quality Indicators in Continuing Care.

Calgary Health Research Day ~ Sponsored by the Calgary Health Region, University of Calgary ~

Faculty of Medicine, Alberta Cancer Board and the AHFMR,

Calgary AB, April 24, 2004.

Maxwell CJ, Zimmerman DR. RAI/MDS Quality Indicators for Internal and External Quality

Monitoring in Continuing Care, Quality Improvement Workshop ~ Seniors’ Health, Chinook Health

Region,

Lethbridge AB, May 8,9, 2003.


Maxwell CJ, Hirdes JP. RAI/MDS and Assessment of Need in Long-Term Care.

2nd Annual Long Term Care Colloquium, Calgary Health Region,

Calgary AB, Nov 2, 2002

Maxwell CJ, Vik SA, Hogan DB, Patten SB, Johnson JA, Romonko-Slack L. Drug Adherence and

Health Outcomes in the Community-Dwelling Elderly: A Comparison of Urban & Rural Home Care

Clients.

Best Practice Rounds-Nursing, Calgary Health Region,

Calgary AB, Oct 21, 2002

Maxwell CJ, Vik SA, Hogan DB. Medication Issues in Home & Facility Care Settings: Assessment

and Outcomes.

Alberta Long Term Care Association Conference on Drug Use and Our Aging Population,

Edmonton AB, May 21, 2002

Maxwell CJ and Eldridge D. Clinical & Quality of Care Applications of the RAI 2.0 for Institutional

Care Screening and Assessment.

Calgary Health Region – Long Term Care Conference,

Calgary AB, November 3rd, 2001.

Maxwell CJ. Clinical & Quality of Care Applications of the RAI/MDS Instruments.

Designs for Dementia: Integrating Systems of Care Conference (Alzheimer Society of Ontario /

Murray Alzheimer Research & Education Program, University of Waterloo / Ministry of Health &

LTC / Ontario Seniors’ Secretariat),

Toronto ON, May 24-25, 2001.

Maxwell CJ. Overview of the Resident Assessment Instrument / Minimum Data Set (RAI/MDS –

version 2) for Facility Based Care.

Carewest – Program Team Leaders,

Calgary AB, Oct 19, 2000

Maxwell CJ. Overview of the Resident Assessment Instrument / Minimum Data Set (RAI/MDS –

version 2) for Facility Based Care.

Carewest – Senior Management,

Calgary AB, July 19, 2000

Maxwell CJ. Prescribing habits in Canada.

Shades of Grey Symposium, Seniors Health, CRHA,

Calgary AB, June 9, 2000

Maxwell CJ. Overview of the Resident Assessment Instrument / Minimum Data Set (RAI/MDS) for

continuing care.

Carewest and CRHA-MDS Software Demonstration Symposium,

Calgary AB, June 21, 1999

Maxwell CJ, Alibhai A. Trends in the Utilization of Health Services by Seniors in Alberta.

Future Scenarios: Continuing Care Service Needs in Alberta Planning Session Conference

Alberta Health and Long Term Care Policy Advisory Committee,

Edmonton AB, June 15, 1999


continuing care.

Capital Care Group,

Edmonton AB, June 15, 1999



continuing care.

Alberta Long Term Care Association – Annual Business Meeting,

Calgary AB, May 11, 1999

Maxwell CJ. Calcium Channel Blockers and Adverse Health Outcomes among Elderly Persons:

Results from the Canadian Study of Health and Aging (CSHA).

Institute of Health Economics,

Edmonton AB, April 28, 1999


continuing care.

Carewest Senior Management Meeting,

Calgary AB, March 23, 1999

Maxwell CJ. Behavioural Disturbance Measures: Chronic Psychiatric and Psychogeriatric Patient

Assessment.

Joint Policy and Planning Committee (JPPC - Ontario Ministry of Health/Ontario Hospital

Association) Psychiatric Working Group,

Toronto ON, December 11-13, 1996

Maxwell CJ. Factors Important in Promoting Breast Cancer Screening Behaviour among Older

Women.

Health Sciences Divisional Meeting at the 25th Annual Scientific and Educational Meeting of the

Canadian Association on Gerontology,

Quebec City, Quebec, October, 1996

X. PUBLICATIONS / PRESENTATIONS

Note: Author(s) underlined represent graduate students, post-doctoral fellows, research associates &

clinical residents under my supervision. This supervision involved all aspects from design to final

write-up. In addition, my role as senior (and corresponding) author is generally indicated by the listing

of my name in the second or last position in the list of authors.

(i) Peer Reviewed Manuscripts

124. Sheikh F, Ismail Z, Mortby ME, Barger P, Cieslak A, Fischer K, Granger R, Hogan DB, Mackie

A, Maxwell CJ, Menon B, Mueller P, Patry D, Pearson D, Quickfall J, Sajobi T, Tse E, Wang

M, Smith EE. Prevalence of mild behavioural impairments in mild cognitive impairment and

subjective cognitive decline, and its association with caregiver burden. In press, International

Psychogeriatrics, July, 2017.

123. Maclagan LC, Maxwell CJ, Gandhi S, Guan J, Bell C, Hogan D, Daneman N, Gill S, Morris A,

Jeffs L, Campitelli M, Seitz D, Bronskill SE. Frailty and potentially inappropriate medication

use at nursing home transition. In press, JAGS, June 2017.

122. Campitelli MA, Maxwell CJ, Giannakeas V, Bell CM, Daneman N, Jeffs L, Morris AM, Austin

PC, Hogan DB, Ko DT, Lapane KL, Maclagan LC, Seitz DP, Bronskill SE. The variation of

statin use among nursing home residents and physicians: A cross-sectional analysis. In press,

JAGS, June 2017.

121. Stock KJ, Hogan DB, Lapane K, Amuah JE, Tyas SL, Bronskill SE, Morris AM, Bell CM, Jeffs

L, Maxwell CJ. Antipsychotic use and hospitalization among older assisted living residents:

Does risk vary by frailty status? Am J Ger Psych 2017;25(7):779-90.


120. Daneman N, Campitelli MA, Giannakeas V, Morris AM, Bell CM, Maxwell CJ, Jeffs L, Austin

PC, Bronskill SE. Influences on the start, selection and duration of treatment with antibiotics

in long-term care. CMAJ 2017 June 26;189:E851-60. doi: 10.1503/cmaj.161437. Visual

abstract available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.161437/-/DC2.

119. Mondor L, Maxwell CJ, Hogan DB, Bronskill SE, Gruneir A, Lane NE, Wodchis WP.

Multimorbidity and healthcare utilization among home care clients with dementia in Ontario,

Canada: A retrospective analysis of a population-based cohort. PLoS Med [Special Issue on

Dementia] 2017;14(3):e1002249. doi:10.1371/journal.pmed.1002249.

118. Hogan DB, Maxwell CJ, Afilalo J, Arora RC, Bagshaw S, Basran J, Bergman H, Bronskill SE,

Carter C, Dixon E, Hemmelgarn B, Madden K, Mitnitski A, Rolfson D, Stelfox HT, Tam-

Tham H, Wunsch H. A scoping review of frailty and acute care in middle-aged and older

individuals with recommendations for further research. Can Ger J Dec 2017;20(1):22-37..

117. Stock KJ, Amuah JE, Lapane KL, Hogan DB, Maxwell CJ. Prevalence of, and resident and

facility characteristics associated with antipsychotic use in assisted living vs. long-term care

facilities: A cross-sectional analysis from Alberta, Canada. Drugs Aging 2017;34(1):39-53.

116. Kirkham J, Sherman C, Velkers C, Maxwell C, Gill SS, Rochon PA, Seitz D. Antipsychotic use

in dementia. Can J Psychiatry 2017;62(3):170-181.

115. Wilcox ME, Freiheit EA, Faris P, Hogan DB, Patten SB, Anderson T, Ghali WA, Knudtson M,

Demchuk A, Maxwell CJ. Depressive symptoms and functional decline following coronary

interventions in older patients with coronary artery disease: A prospective cohort study. BMC

Psychiatry 2016;16:277.

114. Petrosyan Y, Bai YQ, Koné Pefoyo AJ, Gruneir A, Thavorn K, Maxwell CJ, Bronskill SE,

Wodchis WP. The relationship between diabetes care quality and diabetes-related

hospitalizations, and the modifying role of comorbidity. Can J Diabetes 2017;41(1):17-25.

113. Campitelli MA, Bronskill SE, Hogan DB, Diong C, Amuah JE, Gill S, Seitz D, Thavorn K,

Wodchis WP, Maxwell CJ. The prevalence and health consequences of frailty in a

population-based older home care cohort: A comparison of different measures. BMC

Geriatrics 2016;16:133.

112. Muscedere J, Andrew MK, Bagshaw SM, Estabrooks C, Hogan D, Holroyd-Leduc J, Howlett S,

Lahey W, Maxwell C, McNally M, Moorhouse P, Rockwood K, Rolfson D, Sinha S, Tholl B.

Screening for frailty in Canada’s health care system: A time for action. Can J Aging

2016;35(3):281-297.

111. Mondor L, Maxwell CJ, Bronskill SE, Gruneir A, Wodchis WP. The relative impact of chronic

conditions and multimorbidity on health-related quality of life in Ontario long-stay home care

clients. Qual Life Res 2016;25(10):2619-2632.

110. Gruneir A, Bronskill SE, Maxwell CJ, Bai Y, Kone A, Thavorn K, Petrosyan Y, Calzavara A,

Wodchis WP. The association between multimorbidity and hospitalization is modified by

individual demographics and physician continuity of care: a retrospective cohort study. BMC

Health Services Research 2016;16:154. DOI: 10.1186/s12913-016-1415-5

109. Freiheit EA, Hogan DB, Patten SB, Wunsch H, Anderson T, Ghali WA, Knudtson M, Maxwell

CJ. Frailty trajectories after treatment for coronary artery disease in older patients. Circ

Cardiovasc Qual Outcomes 2016;9:230-238. doi: 10.1161/CIRCOUTCOMES.115.002204.


[with editorial by Afilalo J. Circ Cardiovasc Qual Outcomes 2016;9:194-96. doi:

10.1161/CIRCOUTCOMES.116.002852.]

108. Fiest KM, Roberts JI, Maxwell CJ, Hogan DB, Smith EE, Frolkis A, Cohen A, Kirk A, Pearson

D, Pringsheim T, Venegas-Torres A, Jetté N. The prevalence and incidence of dementia due

to Alzheimer disease: a systematic review and meta-analysis. Can J Neurol Sci

2016;43(Suppl 1):S51-82.

107. Hogan DB, Jetté N, Fiest KM, Roberts JI, Pearson D, Smith EE, Roach P, Kirk A, Pringsheim T,

Maxwell CJ. The prevalence and incidence of frontotemporal dementia: a systematic review.

Can J Neurol Sci 2016;43(Suppl 1):S96-109.

106. Cepoiu-Martin M, Tam-Tham H, Patten S, Maxwell C, Hogan DB. Predictors of long-term care

placement in persons with dementia: a systematic review and meta-analysis. Int J Geriatr

Psychiatry 2016;31(11):1151-1171.

105. Jetté N, Maxwell CJ, Fiest KM, Hogan DB. Systematic reviews and meta-analyses of the

incidence and prevalence of dementia and its commoner neurodegenerative causes. In press,

Can J Neurol Sci 2016;43(Suppl 1):S1-2.

104. Fiest KM, Jetté N, Roberts JI, Maxwell CJ, Smith EE, Black S, Blaikie L, Cohen A, Day L,

Holroyd-Leduc J, Kirk A, Pearson D, Pringsheim T, Venegas-Torres A, Hogan DB. The

prevalence and incidence of dementia: a systematic review and meta-analysis. Can J Neurol

Sci 2016;43(Suppl 1):S3-50.

103. Hogan DB, Fiest KM, Roberts JI, Maxwell CJ, Dykeman J, Pringsheim T, Steeves T, Smith EE,

Pearson D, Jetté N. The prevalence and incidence of dementia with Lewy Bodies: a

systematic review. Can J Neurol Sci 2016;43(Suppl 1):S83-95.

102. Bansal S, Hirdes JP, Maxwell CJ, Papaioannou A, Giangregorio LM. Identifying Fallers among

Home Care Clients with Dementia and Parkinson’s Disease. Can J Aging 2016;35(3):319-

331.

101. Lane NE, Maxwell CJ, Gruneir A, Bronskill SE, Wodchis WP. Absence of a socioeconomic

gradient in older adults’ survival with multiple chronic conditions. EBioMedicine 2015;2:

2094-2100.

100. Marshall DA, Vanderby S, Barnabe C, MacDonald KV, Maxwell C, Mosher D, Wasylak T, Lix

L, Enns E, Frank C, Noseworthy T. Estimating the burden of osteoarthritis to plan for the

future. Arthritis Care & Research 2015;67(10):1379-1386.

99. Koné Pefoyo A, Bronskill SE, Gruneir A, Calzavara A, Thavorn K, Petrosyan Y, Maxwell CJ, Bai

Y, Wodchis W. The increasing burden and complexity of multimorbidity. BMC Public Health

2015;15:415.

98. Maxwell CJ, Amuah JE, Hogan DB, Cepoiu-Martin M, Gruneir A, Patten SB, Soo A, Le Clair K,

Wilson K, Hagen B, Strain LA. Elevated hospitalization risk of assisted living residents with

dementia in Alberta, Canada. Journal of the American Medical Directors Association 2015

16(7):568-77.

97. Patten SB, Burton J, Fiest KM, Wiebe S, Bulloch AGM, Koch M, Dobson KS, Metz LM,

Maxwell CJ, Jetté N. Validity of four screening scales for major depression in MS. Multiple

Sclerosis Journal 2015;21(8):1064-71.


96. Maxwell CJ, Stock K, Seitz D, Herrmann N. Persistence and adherence with dementia

pharmacotherapy: relevance of patient, provider and system factors. Can J Psychiatry 2014;

59(12):624-631.

95. Fiest KM, Patten SB, Altura KC, Bulloch AGM, Maxwell CJ, Wiebe S, Macrodimitris S, Jetté N.

Patterns and frequency of the treatment of depression in persons with epilepsy. Epilepsy &

Behavior 2014;39:59-64.

94. Fiest KM, Patten SB, Wiebe S, Bulloch AGM, Maxwell CJ, Jetté N. Validating screening tools for

depression in epilepsy. Epilepsia 2014;55(10):1642-50.

93. Danila O, Hirdes JP, Maxwell CJ, Marrie RA, Patten SB, Pringsheim T, Jetté N. Prevalence of

neurological conditions across the continuum of care based on interRAI assessments. BMC

Health Services Research 2014;14:29.

92. Hogan DB, Amuah JE, Strain LA, Wodchis WP, Soo A, Eliasziw M, Gruneir A, Hagen B, Teare

G, Maxwell CJ. High hospitalization rates among older residents in assisted living facilities:

opportunities for intervention and impact on acute care. Open Medicine 2014;8(1):33-45.

91. Vu M, Hogan DB, Patten SB, Jetté N, Bronskill SE, Heckman G, Kergoat M-J, Hirdes JP, Chen

X, Zehr M, Maxwell CJ. A comprehensive profile of the sociodemographic, psychosocial and

health characteristic of Ontario home care clients with dementia. Chronic Diseases & Injuries

in Canada 2014;34(2-3): 132-144.

90. Pringsheim T, Lam D, Day L, Genge A, Hogan DB, Shevell M, Fortin CM, Maxwell C,

Fiebelkorn G, Barlow K, Kapral MK, Casha S, Mobach T, Johnston M, Korngut L, Jetté N.

Validation and interpretation of neurological registry data. Can J Neurol Sci 2013;40:Suppl.

2:S54-56.

89. Johnston M, Campbell C, Hayward R, Lowerison M, Noonan VK, Pfister T, Maxwell C, Fortin

CM, Smith E, Mah JK, Kapral MK, Jetté N, Pringsheim T, Korngut L. Registry data storage

and curation. Can J Neurol Sci 2013;40: Suppl. 2:S38-43.

88. Jetté N, Atwood K, Hamilton M, Hayward R, Day L, Mobach T, Maxwell C, Fortin CM,

Fiebelkorn G, Barlow K, Shevell M, Kapral MK, Casha S, Johnston M, Wiebe S, Korngut L,

Pringsheim T. Linkage between neurological registry data and administrative data. Can J

Neurol Sci 2013;40: Suppl. 2:S35-37.

87. Smith E, Warner J, Johnston M, Atwood K, Hall R, Mah JK, Maxwell C, Fortin CM, Lowerison

M, Kapral MK, Noonan VK, Pfister T, MacKean G, Casselman L, Pringsheim T, Jetté N,

Korngut L. Neurological registry data collection methods and configuration. Can J Neurol Sci

2013;40:Suppl. 2:S29-34.

86. Maxwell CJ, Vu M, Hogan DB, Patten SB, Jantzi M, Kergoat M-J, Jetté N, Bronskill SE,

Heckman G, Hirdes JP. Patterns of dementia pharmacotherapy in a population-based cohort

of home care clients. Drugs Aging 2013;30(7):569-85.

85. Maxwell CJ, Soo A, Hogan DB, Wodchis WP, Amuah JE, Gilbart E, Eliasziw M, Hagen B, Strain

LA. Predictors of nursing home placement from assisted living settings in Canada. Canadian

Journal on Aging / La Revue canadienne du vieillissement 2013;32(4):333-48, Available on

CJO 2013 doi:10.1017/S0714980813000469.

84. Tam-Tham H, Cepoiu-Martin M, Ronksley PE, Maxwell CJ, Hemmelgarn BR. Dementia case

management and risk of long-term care placement: a systematic review and meta-analysis. Int

J Geriatr Psychiatry 2013; 28:889-902.


83. Hogan DB, Freiheit EA, Strain LA, Patten SB, Schmaltz HN, Rolfson D, Maxwell CJ. Comparing

frailty measures in their ability to predict adverse outcomes among older residents of assisted

living. BMC Geriatrics 2012;12:56.

82. Fiest KM, Dykeman J, Patten SB, Wiebe S, Kaplan GG, Maxwell CJ, Bulloch AGM, Jette N.

Depression in Epilepsy: A Systematic Review and Meta-Analysis. Neurology 2013;80:1-10.

(with accompanying editorial and podcast).

81. Freiheit EA, Hogan DB, Eliasziw M, Patten SB, Demchuk AM, Faris P, Anderson T, Galbraith D,

Parboosingh JS, Ghali WA, Knudtson M, Maxwell CJ. A dynamic view of depressive

symptoms and neurocognitive change among patients with coronary artery disease. Arch Gen

Psychiatry 2012;69:244-255.

80. Hirdes JP, Mitchell L, Maxwell CJ, White N. Beyond the “Iron Lungs of Gerontology”: Using

evidence to shape the future of nursing homes in Canada. Can J Aging 2011;30(3):371-390.

79. Freiheit EA, Hogan DB, Strain LA, Schmaltz HN, Patten SB, Eliasziw M, Maxwell CJ.

Operationalizing frailty among older residents of assisted living facilities. BMC Geriatrics

2011;11:23.

78. Foebel AD, Heckman GA, Hirdes JP, Tyas SL, Tjam EY, McKelvie RS, Maxwell CJ. Clinical,

demographic and functional characteristics associated with pharmacotherapy for heart failure

in older home care clients. Drugs Aging 2011;28(7):561-73.

77. Rawson NSB, Downey W, Maxwell CJ, West R. 25 years of pharmacoepidemiologic innovation:

The Saskatchewan Health Administrative Databases. Journal of Population Therapeutics &

Clinical Pharmacology 2011;18(2):e245-9.

76. Sales A, O’Rourke H, Draper K, Teare GF, Maxwell CJ. Prioritizing information for quality

improvement using resident assessment instrument data: experiences in one Canadian

province. Healthcare Policy 2011;6(3):55-67.

75. Freiheit EA, Hogan DB, Eliasziw M, Meekes M, Ghali WA, Partlo L, Maxwell CJ. The

development of a frailty index for patients with coronary artery disease. Journal of the

American Geriatrics Society 2010;58:1526-31.

74. Amuah JE, Hogan DB, Eliasziw M, Supina AL, Beck P, Downey W, Maxwell CJ. Persistence

with cholinesterase inhibitor therapy in a population-based cohort of patients with

Alzheimer’s disease. Pharmacoepidemiology & Drug Safety 2010;19:670-9.

73. Maxwell CJ, Hogan DB. Antihypertensive agents and the prevention of dementia. BMJ

2010;340:b5409 (invited editorial).

72. Maxwell CJ, Kang J, Walker JD, Zhang JX, Hogan DB, Feeny DH, Wodchis WP. Sex differences

in the relative contribution of social and clinical factors to the Health Utilities Index Mark 2

measure of health-related quality of life in older home care clients. Health and Quality of Life

Outcomes 2009, 7:80.

71. Giangregorio LM, Jantzi M, Papaioannou A, Hirdes J, Maxwell CJ, Poss JW. Osteoporosis

management among residents living in long term care. Osteopor Int 2009;20(9):1471-8.

70. Walker JD, Teare GF, Hogan DB, Lewis S, Maxwell CJ. Identifying potentially avoidable

hospital admissions from Canadian long-term care facilities. Medical Care 2009;47(2):250-4.


69. Wang JL, Keown LA, Patten SB, Williams JA, Currie SR, Beck CA, Maxwell CJ, El-Guebaly

NA. A population based study on ways of dealing with daily stress: Comparisons among

individuals with mental disorders, with long-term general medical conditions and healthy

people. Soc Psychiatry Psychiatr Epidemiol 2009;44:666-74.

68. Sittisombut S, Maxwell CJ, Love EJ, Sitthi-Amorn C. Physicians’ attitudes and practice towards

advanced end-of-life care planning in terminally ill patients at Chiang Mai University

Hospital, Thailand. Nursing & Health Sciences 2009; 11: 23-28.

67. Schmaltz HN, Southern DA, Maxwell CJ, Knudtson ML, Ghali WA for the APPROACH

Investigators. Patient sex does not modify ejection fraction as a predictor of death in heart

failure: Insights from the APPROACH cohort. Journal of General Internal Medicine

2008;23(12):1940-6.

66. Southern DA, Lewis S, Maxwell CJ, Dunn JR, Noseworthy TW, Corbett G, Thomas K, Ghali

WA. Sampling ‘hard-to-reach’ populations in health research: Yield from a study targeting

Americans living in Canada. BMC Medical Research Methodology 2008, 8:57.

65. Campbell NRC, So L, Amankwah E, Quan H, Maxwell C, for the Canadian Hypertension

Education Program Outcomes Research Task Force. Characteristics of hypertensive

Canadians not receiving drug therapy. Canadian Journal of Cardiology 2008;24(6):485-90.

64. Maxwell CJ, Dalby DM, Slater M, Patten SB, Hogan DB, Eliasziw M, Hirdes JP. The prevalence

and management of current daily pain among older home care clients. Pain 2008;138:208-16.

63. Dalby DM, Hirdes JP, Hogan DB, Patten SB, Beck CA, Rabinowitz T, Maxwell CJ. Potentially

inappropriate management of depressive symptoms among Ontario home care clients. Int J

Geriatr Psychiatr 2008;23:650-9.

62. Sittisombut S, Maxwell CJ, Love EJ, Sitthi-Amorn C. Effectiveness of advance directives for the

care of terminally ill patients in Chiang Mai University Hospital, Thailand. Nursing & Health

Sciences 2008;10:37-42.

61. Amankwah E, Campbell NRC, Maxwell CJ, Onysko J, Quan H. Why some adult Canadians do

not have blood pressure measured. J Clin Hypertension 2007;9 (12):944-51.

60. Middleton LE, Kirkland SA, Maxwell CJ, Hogan DB, Rockwood K. Exercise: A potential

contributing factor to the relationship between folate and dementia. J Am Ger Soc

2007;55:1095-8.

59. Lewis S, Southern D, Maxwell CJ, Dunn JA, Noseworthy TN, Ghali WA. What Americans living

in Canada think of the Canadian and American Health Care Systems. Open Medicine 2007

1(2):E68-74.

58. Supina AL, Johnson JA, Patten SB, Williams JV, Maxwell CJ. The usefulness of the EQ-5D in

differentiating among persons with major depressive episode and anxiety. Quality of Life

Research 2007;16:749-54.

57. Schmaltz HN, Southern D, Ghali WA, Jelinski SE, Parsons GA, King K, Maxwell CJ. Living

alone, patient sex and mortality after acute myocardial infarction. J Gen Intern Med

2007;22(5):572-578.

56. El-Guebaly N, Currie S, Williams J, Wang JL, Beck CA, Maxwell C, Patten SB. Association of

mood, anxiety and substance use disorders with occupational status and disability in a

community sample. Psychiatric Services 2007; 58(5):659-667.


55. Vik SA, Jantzi M, Poss J, Hirdes JP, Hanley DA, Hogan DB, Maxwell CJ. Factors associated with

the pharmacologic treatment of osteoporosis in an older home care population. J Gerontol

Med Sci 2007; 62A (8):872-8.

54. Wodchis WP, Maxwell CJ, Venturini A, Walker JD, Zhang J, Hogan DB, Feeny DH. Study of

observed and self-reported HRQL in older frail adults finds group-level congruence and

individual-level differences. Journal of Clinical Epidemiology 2007;60:502-511.

53. Onysko J, Maxwell C, Eliasziw M, Zhang JX, Johansen H, Campbell NRC, for the Canadian

Hypertension Education Program. Large increases in hypertension diagnosis and treatment in

Canada after a healthcare professional education program. Hypertension 2006;48(5):853-860.

52. Maxwell CJ, Onysko J, Bancej CM, Nichol M, Rakowski W. The distribution and predictive

validity of the stages of change for mammography adoption among Canadian women.

Preventive Medicine 2006; 43:171-77.

51. Zhang JX, Walker JD, Wodchis WP, Hogan DB, Feeny DH, Maxwell CJ. Measuring health status

and decline in at-risk seniors residing in the community using the Health Utilities Index

Mark2. Qual Life Res 2006;15(8):1415-26.

50. El-Guebaly N, Patten SB, Currie S, Williams JVA, Beck CA, Maxwell CJ, Wang JL.

Epidemiological associations between gambling behavior, substance use and mood and

anxiety disorders. J Gambling Studies 2006;22:275-87.

49. Vik SA, Hogan DB, Patten SB, Johnson JA, Romonko-Slack L, Maxwell CJ. Medication

nonadherence and subsequent risk of hospitalization and mortality in older adults. Drugs and

Aging 2006;23(4):345-56.

48. Patten SB, Wang JL, Williams JVA, Currie S, Beck CA, Maxwell CJ, el-Guebaly N. Descriptive

epidemiology of major depression in Canada. Can J Psychiatry 2006;51(2):84-90.

47. Beck CA, Patten SB, Williams JVA, Wang JL, Currie SR, Maxwell CJ, El-Guebaly N.

Antidepressant utilization in Canada. Soc Psychiatry Psychiatr Epidemiol 2005;40:799-807.

46. Patten SB, Wang JL, Beck CA, Maxwell CJ. Measurement Issues Related to the Evaluation and

Monitoring of Major Depression Prevalence in Canada. Chronic Diseases in Canada 2005;26

(4):100-6.

45. Beck CA, Williams JVA, Wang JL, Kassam A, Currie SR, Maxwell CJ, El-Guebaly N, Patten SB.

Psychotropic medication use in Canada. Can J Psychiatry 2005;50(10):605-13.

44. Wang JL, Patten SB, Williams J, Currie S, Beck C, Maxwell CJ, El-Guebaly N. Help-seeking

behaviours of individuals with mood disorders. Can J Psychiatry 2005;50(10):652-59.

43. Currie SR, Patten SB, Williams J, Wang JL, Beck CA, El-Guebaly N, Maxwell C. Comorbidity of

major depression with substance use disorders. Can J Psychiatry 2005;50(10):660-x.

42. Bancej CM, Maxwell CJ, Onysko J, Eliasziw M. Mammography utilization in Canadian women

aged 50-69: Identification of factors that predict initiation and adherence. Can J Public

Health 2005;96(5):364-8.

41. Maxwell CJ, Hicks MS, Hogan DB, Basran J, Ebly EM. Supplemental use of antioxidant vitamins

and subsequent risk of cognitive decline and dementia. Dementia & Geriatric Cognitive

Disorders 2005;20:45-51.


40. Vik SA, Maxwell CJ, Hogan DB, Patten SB, Johnson JA, Romonko-Slack L. Assessing

Medication Adherence among Older Persons in Community Settings. Can J Clin Pharmacol

2005;12(1): e152-64.

39. Jelinski SE, Maxwell CJ, Onysko J, Bancej CM. The influence of breast self-examination on

subsequent mammography participation. Am J Public Health 2005;95(3):506-11.

38. Vik SA, Hanley D, Maxwell CJ. Treatment of Osteoporosis in an Older Home Care Population.

BMC Musculoskeletal Disorders 2005;6:7.

37. Bancej CM, Maxwell CJ, Snider J. Inconsistent self-reported mammography history: Findings

from the National Population Health Survey longitudinal cohort. BMC Health Services

Research 2004;4:32 (http://www.biomedcentral.com/1472-6963/4/32).

36. Walker JD, Maxwell CJ, Hogan DB, Ebly EM. Does self-rated health predict survival in older

persons with cognitive impairment? Journal of the American Geriatrics Society

2004;52:1895-1900.

35. Jelinski SE, Ghali WA, Parsons GA, Maxwell CJ. Absence of sex differences in pharmacotherapy

for acute myocardial infarction. Can J Cardiology 2004; 20(9):899-905.

34. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates and health outcomes of medication

adherence among seniors. Annals of Pharmacotherapy 2004;38:303-12.

33. Hogan DB, Maxwell CJ, Fung TS, Ebly EM. Regional variation in the use of medications by older

Canadians: A persistent and incompletely understood phenomena. Pharmacoepidemiology

and Drug Safety 2003;12:575-82.

32. Walker JD, Maxwell CJ, Wodchis WP. Understanding health-related quality of life in older

persons. Stride: Excellence in Seniors Care 2003;5(4):10-14.

31. Victorino CC, Maxwell CJ, Hogan DB. The prevalence and pharmacological management of pain

among older home care clients. Stride: Excellence in Seniors Care 2003;5(3):4-9.

30. Hogan DB, Maxwell CJ, Fung TS, Ebly EM. Prevalence and potential consequences of

benzodiazepine use in seniors: Results from the Canadian Study of Health and Aging. Can J

Clin Pharmacol 2003;10(2):72-7.

29. Patten SB, Stuart HL, Russell ML, Maxwell CJ, Arboleda-Florez J. Epidemiology of major

depression in a predominantly rural health region. Soc Psychiatry Psychiatr Epidemiol

2003;38(7):360-5.

28. Ghali WA, Donaldson CR, Knudtson ML, Lewis SJ, Maxwell CJ, Tu JV. Rising to the challenge:

transforming the treatment of ST-segment elevation myocardial infarction. CMAJ

2003;169:35-7.

27. Challiner Y, Carpenter GI, Potter J, Maxwell CJ. Performance indicators for hospital services for

older people. Age and Ageing 2003;32:343-6.

26. Hogan DB, Maxwell CJ, Ebly EM. Use of complementary and alternative medicines by older

individuals: Results from the Canadian Study of Health and Aging. Geriatrics Today: Journal

of the Canadian Geriatrics Society 2003;6:21-5.

http://www.biomedcentral.com/1472-6963/4/32


25. Maxwell CJ, Hogan DB, Ebly EM. Serum folate levels and subsequent adverse cerebrovascular

outcomes in elderly persons. Dementia & Geriatric Cognitive Disorders 2002;13(4):225-34.

24. Madden KM, Hogan DB, Maxwell CJ, Ebly EM. The prevalence of geriatric syndromes and their

effect on the care and outcome of patients aged 75 years of age and older presenting to an

emergency department. Geriatrics Today: J Can Geriatr Soc 2002;5:69-75.

23. Neutel CI, Perry S, Maxwell CJ. Medication use and risk of falls. Pharmacoepidemiology and

Drug Safety 2002;11(2):97-104 (with editorial pp. 95-6).

22. Lewis S, Maxwell CJ. Decoding Mazankowski: A Symphony In Three Movements. Healthcare

Papers 2002;2(4):20-6.

21. Church DL, Davies HD, Mitton C, Semeniuk H, Logue M, Maxwell C, Donaldson C. Clinical and

Economic Evaluation of Rapid Influenza A Testing in Nursing Homes in Calgary. Clinical

Infectious Diseases 2002;34(6):790-5.

20. Saunders LD, Alibhai A, Hogan DB, Maxwell CJ, Quan H, Johnson D. Trends in the Utilization

of Health Services by Seniors in Alberta. Canadian Journal on Aging 2001;20(4):493-516.

19. Hogan DB, Macdonald FA, Betts J, Bricker S, Ebly EM, Delarue B, Fung TS, Harbidge C, Hunter

M, Maxwell CJ, Metcalf B. A randomized controlled trial of a community-based consultation

service to prevent falls. Canadian Medical Association Journal 2001;165:537-43 (with

commentary pp. 587-8).

18. Maxwell CJ, Bancej CM, Snider J, Vik SA. Factors important in promoting cervical cancer

screening among Canadian women: findings from the 1996-97 National Population Health

Survey (NPHS). Canadian Journal of Public Health 2001;92:127-33.

17. Maxwell CJ. The promise of better care – commentary: Development of the Resident Assessment

Instrument – Mental Health (RAI-MH). Hospital Quarterly (Invited) Winter

2000/2001;4(2):53.

16. Maxwell CJ, Bancej CM, Snider J. Predictors of mammography use among Canadian women

aged 50-69: findings from the 1996-97 National Population Health Survey. Canadian

Medical Association Journal 2001;164(3):329-34.

15. Maxwell CJ, Hogan DB, Hirdes JP. The Prevalence and Treatment of Hypertension in Long Term

Care Settings: Implications for Quality of Care of the Frail Elderly. Annals of Long-Term

Care: Clinical Care and Aging 2000;8(11):31-6.

14. Russell ML, Maxwell CJ. The Prevalence and Correlates of Influenza Vaccination among a

Home Care Population. Can J Public Health 2000;91(6):441-4.

13. Hirdes JP, Ikegami N, Jónsson PV, Topinková E, Maxwell CJ, Yamauchi K. Cross-National

Comparisons of Antidepressant Use among Institutionalized Older Persons Based on the

Minimum Data Set (MDS). Canadian Journal on Aging-Special Journal Issue on RAI/MDS

2000;19 (supplement 2):18-37.

12. Maxwell CJ, Hogan DB, Campbell NRC, Ebly EM. Nifedipine and mortality risk in the elderly:

Relevance of drug formulation, dose and duration. Pharmacoepidemiology and Drug Safety,

2000;9(1): 11-23.


11. Neutel CI, Maxwell CJ, Appel WC. Differences between males and females in risk of NSAID-

related severe gastrointestinal events. Pharmacoepidemiology and Drug Safety

1999;8(7):501-507.

10. Maxwell CJ, Hogan DB, Ebly EM. Calcium Channel Blockers and Cognitive Function in Elderly

People – Results from the Canadian Study of Health and Aging. Canadian Medical

Association Journal 1999; 161:501-510 (with editorial pp. 534-5).

9. Maxwell CJ, Oakley K. Older Women’s Health Issues. Canadian Journal on Aging (editorial)

1998;17(2):i-ix.

8. Maxwell CJ, Zimmerman DR, Karon SL, Sainfort F, Purnell M. Estimating Quality Indicators for

Chronic Care from the MDS 2.0: Risk Adjustment Issues and Concerns. Canadian Journal of

Quality in Health Care 1998;14(3):4-13.

7. Maxwell CJ, Kozak JF, Desjardins-Denault S, Parboosingh J. Factors Important in Promoting

Mammography Screening among Canadian Women. Canadian Journal of Public Health

1997; 88(5):346-350.

6. Maxwell CJ, Neutel CI, Hirdes JP. A Prospective Study of Falls after Benzodiazepine Use: A

Comparison of New and Repeat Use. Pharmacoepidemiology and Drug Safety 1997; 6:27-36.

5. Neutel CI, Hirdes JP, Maxwell CJ, Patten SB. New Evidence on Benzodiazepine Use and Falls –

the Time Factor. Age and Ageing 1996; 25:273-278.

4. Neutel CI, Maxwell CJ. The Benzodiazepine Treadmill: Does One Prescription Lead to More?

Pharmacoepidemiology and Drug Safety 1996; 5:39-42.

3. Forbes WF, Gentleman JF, Maxwell CJ. Concerning the role of Aluminum in causing Dementia.

Experimental Gerontology 1995;30:23-32.

2. Hirdes JP, Maxwell CJ. Smoking Cessation and Quality of Life Outcomes among Older Adults in

the Campbell’s Survey on Well-Being. Canadian Journal of Public Health 1994;85:99-102.

1. Maxwell CJ, Hirdes JP. The Prevalence of Smoking and Implications for Quality of Life Among

the Community-Based Elderly. American Journal of Preventive Medicine 1993;9:338-345.

(ii) Submitted Peer Reviewed Manuscripts

Thavorn K, Maxwell CJ, Gruneir A, Bronskill SE, Kone A, Petrosyan Y, Qing Y, Wodchis WP. The

effect of socio-demographic factors on the association between multimorbidity and healthcare

costs: A Population-based study. Revise & Resubmit, BMJ Open May 2017.

Maxwell CJ, Campitelli MA, Hogan DB, Diong C, Austin PC, Amuah JE, Lapane K, Seitz DP, Gill

SS, Gruneir A, Wodchis WP, Bronskill SE. Relevance of frailty to mortality associated with

the use of antipsychotics among community-residing older adults with impaired cognition.

Submitted to Pharmacoepidemiology & Drug Safety, May 2017.

Macri J, Iaboni A, Kirkham J, Maxwell CJ, Gill SS, Vasudev A, Whitehead M. Fall-related injuries

among long-term care residents newly initiating antidepressants: A population-based study.

Revise and Resubmit, Am J Geriatr Psychiatry, January 2017.


(iii) Non-Peer Reviewed Manuscripts

Hogan DB, Maxwell CJ, Afilalo J, Arora RC, Bagshaw S, Basran J, Bergman H, Bronskill SE, Dixon

E, Hemmelgarn B, Madden K, Mitnitski A, Rolfson D, Stelfox HT, Tam-Tham H, Wunsch H.

A critical review of frailty and acute care: recommendations for further research. Discussion

paper based on a CIHR-funded invitational expert consultation meeting on Frailty in Acute

Care, February 2016.

Ng R, Maxwell CJ, Yates EA, Nylen K, Antflick J, Jetté N, Bronskill SE. Brain Disorders in Ontario:

Prevalence, Incidence and Costs from Health Administrative Data. Toronto, ON: Institute for

Clinical Evaluative Sciences, 2015.

Jetté N & Pringsheim T (Eds), on behalf of research team, including Maxwell CJ. Systematic reviews

on the incidence and prevalence of neurological conditions. Technical report for the Public

Health Agency of Canada and the Neurological Health Charities of Canada, June 2013.

Pringsheim T & Jetté N (Eds), on behalf of research team, including Maxwell CJ. Inventory of

existing neurological registries in Canada and selected developed countries: A synthesis.

Technical report for the Public Health Agency of Canada and the Neurological Health

Charities of Canada, June 2013.

Jetté N & Pringsheim T (Eds), on behalf of research team, including Maxwell CJ. Recommendations:

Best sources of ascertainment for neurological conditions for surveillance purposes. Technical

report for the Public Health Agency of Canada and the Neurological Health Charities of

Canada, June 2013.

Fraser K, Schalm C, et al., including Maxwell CJ. Data for improvement and clinical excellence:

Final Research Report. Canadian Foundation for Healthcare Improvement. June 2013

(www.cfhi-fcass.ca)

Hogan DB, Maxwell CJ. Book Chapter: Frailty, hospitalization, and the ability to tolerate intensive

forms of medical therapy. In: La fragilité des personnes âgées: approche globale,

pluridisciplinaire et international. Éditeur: Presses de l'École des Hautes Études en Santé

Publique (EHESP). Date de sortie: Octobre - novembre 2012. [In press]

Strain LA, Maxwell CJ, Wanless D, Gilbart E. Designated Assisted Living (DAL) and Long-Term

Care (LTC) in Alberta: Selected Highlights from the Alberta Continuing Care

Epidemiological Studies (ACCES). Edmonton, AB: ACCES Research Group, University of

Alberta, 2011. http://hdl.handle.net/10402/era.23779

Wanless D, Strain LA, Maxwell CJ. Designated Assisted Living (DAL) and Long-Term Care (LTC) in

Alberta: Alberta Continuing Care Epidemiological Studies (ACCES) Methodology.

Edmonton, AB: ACCES Research Group, University of Alberta, 2011.

http://hdl.handle.net/10402/era.23788

Freiheit EA, Hogan DB, Eliasziw M, Maxwell CJ. Frailty index for patients with coronary artery

disease. (Response to Letter to Editor by Kim & Choi). J Am Geriatr Soc 2011; 59(2):374-5.

Hirdes JP, Poss JW, Fries BE, Smith TF, Maxwell CJ, Wu C, Jantzi M. Canadian Staff Time and

Resource Intensity Verification (CAN-STRIVE) Project: Validation of the Resource

Utilization Groups (RUG-III) and Resource Utilization Groups for Home Care (RUG-III/HC)

Case-mix Systems. Final Report prepared for the Ontario Ministry of Health and Long Term

Care, Nov 2010.




Maxwell CJ, Vik SA, Hogan DB, Patten SB, Johnson JA, Romonko-Slack L. Drug Adherence and

Health Outcomes in the Community Dwelling Elderly: A Comparison of Urban and Rural

Home Care Clients. Working Paper prepared for the Institute of Health Economics, Dec 2002.

Maxwell CJ, Vik SA. Exploring the Balance between Informal and Formal Care in the Community-

Based Elderly. Stride: Excellence in Long Term Care Aug/Oct 2001, 10-5.

Maxwell CJ, Quan H, Hogan DB, Zhang JX. Trends in Hip Fracture Hospitalizations and Associated

Health Outcomes in Alberta 1994-97. Technical Report prepared for the Alberta Centre for

Health Services Utilization Research (ACHSUR), Alberta Health and Wellness, July 2001.

Russell ML, Patten S, Vollman A, Casebeer A, Thurston WE, Maxwell CJ. Client Satisfaction, Health

Status, Service Utilization and Health Behaviours Survey. Report prepared for Headwaters

Health Authority, October, 1999.

Maxwell CJ, Hildebrandt C, Vik SA. Factors Important in Promoting Breast Cancer Screening in

Canadian Women: Comparison of Findings from the 1994-95 & 1996-97 NPHS. Report

prepared for Cancer Bureau, Laboratory Centre for Disease Control, Ottawa ON, August,

1999.

Maxwell CJ, Vik SA. Factors Important in Promoting Cervical Cancer Screening in Canadian

Women: Comparison of Findings from the 1994-95 & 1996-97 NPHS. Report prepared for

Cancer Bureau, Laboratory Centre for Disease Control, Ottawa ON, August, 1999.

Saunders LD, Alibhai A, Hogan DB, Maxwell CJ, Quan H, Johnson D., for The Alberta Centre for

Health Services Utilization Research. Trends in the Utilization of Health Services by Seniors

in Alberta, prepared for Long Term Care Policy Advisory Committee, Alberta, June, 1999.

Maxwell CJ. Inappropriate Prescribing and Adverse Drug Reactions. Health Fact Sheet Series on the

Frail Elderly, prepared for Health Promotion and Programs Branch, Ontario Region, Health

Canada, November, 1998.

Maxwell CJ, Kozak JF, Desjardins-Denault S. Factors Important in Promoting Breast Cancer

Screening Behaviours Among Canadian Women: Regional Comparisons. Report prepared for

Disease Prevention Division, Health Canada, Ottawa ON, April 1996.

Maxwell CJ, Kozak JF, Desjardins-Denault S. Factors Important in Promoting Cervical Cancer

Screening Behaviours Among Canadian Women: Regional Comparisons. Report prepared for

Disease Prevention Division, Health Canada, Ottawa ON, June 1996.

Maxwell CJ. Book Review – Vellas BJ, Albarede JL, Garry PJ (Eds) Facts and Research in

Gerontology 1994: Dementia and Cognitive Impairments. Paris, France: Serdi, 1994, 204

pages, Canadian Journal of Public Health 1995;86(4):286.

Shadbolt-Forbes M, Hirdes JP, Maxwell CJ. The Meaning and Consequences of Smoking Among the

Elderly: Evidence from Community and Institutionalized Settings. Report prepared for

Seniors Independence Program, Health and Welfare, Health Promotion Directorate, Toronto,

ON, March 1992.

Maxwell CJ, Hirdes JP, Forbes WF. An Examination of the Prevalence, Cost-Benefits and Policy

Implications of Smoking Among the Elderly. Report prepared for Seniors Independence

Program, Health and Welfare, Health Promotion Directorate, Toronto, ON, 1991.


Hirdes JP, Maxwell CJ, Shadbolt-Forbes M. The Policy Relevance of the 1990 Canadian General

Social Survey. Report prepared for the Ontario Office for Senior Citizens’ Affairs, Toronto,

ON, 1990.

(iv) Abstracts (published) / Conference Presentations

Oremus M, Maxwell CJ, Tyas S, Konnert C, Law J, Tuokko H. Social support availability and

depressive symptoms among middle- and older-aged Adults: A preliminary analysis of

baseline data from the Canadian Longitudinal Study on Aging. Oral presented at the

Canadian Society for Epidemiology & Biostatistics: 2017 Biennial Conference:

Epidemiology and Biostatistics: From Molecules to Population, Banff, AB, May 30-June 2,

2017.

Oremus M, Tyas S, Maxwell CJ, Tuokko H, Law J, Konnert C. Social support availability and

cognitive function among middle- and older-aged Adults: A cross-sectional analysis of the

Canadian Longitudinal Study on Aging. Oral presented at the Canadian Society for

Epidemiology & Biostatistics: 2017 Biennial Conference: Epidemiology and Biostatistics:

From Molecules to Population, Banff, AB, May 30-June 2, 2017.

Zahradnik M, Jeffs L, Steinberg M, Kruger S, Maxwell C, Bell C, Morris A, Bronskill S. Conditions

and factors associated with potentially inappropriate medication use in frail older adults: a

mixed methods analysis in long-term care. Poster presented at the Canadian Association

for Health Services & Policy Research (CAHSPR) Annual Conference, Toronto, ON, May

24-26, 2017.

Daneman N, Campitelli MA, Giannakeas V, Morris AM, Bell CM, Maxwell CJ, Jeffs L, Austin PC,

Bronskill SE. Prescriber tendencies influence antibiotic initiation, selection and duration in

long term care facilities. Poster presented at the Annual Conference of the Canadian

Association for Clinical Microbiology and Infectious Disease, Toronto, ON, May 3-6,

2017. Abstract published in Journal of the Association of Medical Microbiology and

Infectious Disease Canada 2017;Supplement:105.

Bronskill SE, Guan J, Vermeulen M, Yates E, Ng R, Wang X, Walker J, Maxwell CJ. Trends in

prevalence, incidence, health system use and cost by persons with dementia in Ontario from

2004-2013: a population-based study. Abstract published in International Journal for

Population Data Science 2017;1(1): apr. 2017. ISSN 2399-4908. Available at:

https://ijpds.org/article/view/321

Campitelli MA, Maxwell CJ, Giannakeas V, Morris A, Bell CM, Bronskill SE. Statin therapy and

mortality among new long-term care residents in Ontario, Canada: the contribution of

clinical assessment data to a population-based cohort study. Abstract published in

International Journal for Population Data Science 2017;1(1): apr. 2017. ISSN 2399-4908.

Available at: https://ijpds.org/article/view/337

Seitz D, Woosley R, Baranchuk A, Hussain M, Maxwell CJ, Gill SS. Prevalence and correlates of use

of medications associated with prolongation of the corrected QT interval in older adults.

Poster presented at the 2017 Annual Meeting of the American Association for Geriatric

Psychiatry, Dallas, TX, March 24-27, 2017. Abstract published in Am J Geriatr Psychiatry

2017;25(3)(Suppl 1):S145-6.




Wodchis WP Bai YC, Song K, Thavorn K, Lane N, Bronskill SE, Maxwell CJ, Gruneir A, Kone A.

Population healthcare costs for 17 non-communicable diseases in Ontario, Canada. Poster

presentation, 4th Global Symposium on Health Systems Research, Vancouver BC, Nov 14-

18, 2016.

MacKinley ML, Iraniparast M, Costa SM, Maxwell CJ, Tyas SL. Is bigger better? How brain weight

and cortical atrophy contribute to cognitive resilience. Poster presented at the Canadian

Association on Gerontology, 45th Annual Scientific and Educational Meeting, Montreal,

Quebec, Oct 20-22, 2016.

Maxwell CJ, Stock K, Amuah JE, Lapane KL, Hogan DB. Resident and facility level predictors of

antipsychotic use in assisted living. Poster presentation, 32nd International Conference on

Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, Aug 25-28,

2016. Abstract published in Pharmacoepidemiology and Drug Safety 2016;25(Suppl.

3):363-4.

Stock K, Maxwell CJ, Amuah JE, Lapane K, Tyas SL, Bronskill SE, Morris AM, Bell CM, Jeffs L,

Hogan DB. Antipsychotic use, frailty and health outcomes among residents of assisted

living. Oral presentation, 32nd International Conference on Pharmacoepidemiology &

Therapeutic Risk Management, Dublin, Ireland, Aug 25-28, 2016. Abstract published in

Pharmacoepidemiology and Drug Safety 2016;25(Suppl. 3):263.

Campitelli MA, Maxwell CJ, Giannakeas V, Morris A, Bell CM, Bronskill SE. Statin therapy and

mortality among new long-term care residents in Ontario, Canada: the contribution of

clinical assessment data to a population-based cohort study. Oral presentation,

International Population Data Linkage Conference (IPDLN), Wales, UK, Aug 24-26,

2016.

Bronskill SE, Guan J, Vermeulen M, Yates E, Ng R, Wang X, Walker J, Maxwell CJ. Trends in the

prevalence, incidence, health system use and cost by persons with dementia in Ontario from

2004 to 2013: A population-based study. Poster presentation, International Population

Data Linkage Conference (IPDLN), Wales, UK, Aug 24-26, 2016.

Maxwell CJ, Mondor L, Hogan DB, Bronskill Se, Gruneir A, Lane N, Wodchis WP. Relative impact

of multimorbidity on health-related quality of life: A comparison of persons with and

without dementia. Poster presentation, Alzheimer’s Association International Conference,

Toronto ON, July 22-28, 2016. Abstract published in Alzheimer’s & Dementia: The

Journal of the Alzheimer's Association 2016;[need issue, pg].

Bronskill SE, Gandhi S, Maxwell CJ, Li Q, Campitelli M, Gill SS, Daneman N, Seitz D, Bell C,

Hogan DB. Exposure to potentially inappropriate medication among long-term care

residents with cognitive impairment in Ontario. Is there an association with frailty? Poster

presentation, Alzheimer’s Association International Conference, Toronto ON, July 22-28,

2016. Abstract published in Alzheimer’s & Dementia: The Journal of the Alzheimer's

Association 2016;[need issue, pg].

Bronskill SE, Ng R, Yates E, Nylen K, Antflick J, Jaakkimainen L, Tu K, Hogan DB, Maxwell CJ.

Trends in dementia prevalence, incidence and health system costs: A population-based

analysis from Ontario, Canada. Poster presentation, Alzheimer’s Association International

Conference, Toronto ON, July 22-28, 2016. Abstract published in Alzheimer’s &

Dementia: The Journal of the Alzheimer's Association 2016;[need issue, pg].

Ismail Z, Barber P, Cieslak A, Fischer K, Granger R, Hogan DB, Jones H, Mackie A, Maxwell CJ,

Menon B, Mueller P, Palmer A, Patry D, Pearson D, Pomerance B, Quickfall J, Tse E,

Smith EE. Prevalence of mild behavioral impairment (MBI) in a memory clinic population


and the impact on caregiver burden. Poster presentation, Alzheimer’s Association

International Conference, Toronto ON, July 22-28, 2016. Abstract published in

Alzheimer’s & Dementia: The Journal of the Alzheimer's Association 2016;[need issue,

pg].

Iraniparast M, Wu Y, Zeng L, Maxwell CJ, Kryscio RJ, St. John PD, SantaCruz KS, Tyas SL.

Cognitive resilience predicts reverse transitions from mild cognitive impairment to normal

cognition: Findings from the Nun Study. Poster presentation [winner of best student poster

in Public & Psychosocial Theme], Alzheimer’s Association International Conference,

Toronto ON, July 22-28, 2016. Abstract published in Alzheimer’s & Dementia: The

Journal of the Alzheimer's Association 2016;[need issue, pg].

Campitelli M, Maxwell CJ, Austin P, Giannakeas V, Bronskill SE, on behalf of the FRAMING-LTC

Research Team. The variation of statin therapy among long-term care residents, physicians

and facilities in Ontario. Poster presentation, AcademyHealth Annual Research Meeting,

Boston, MA, June 26-28, 2016.

Bronskill SE, Walker JD, Vermeulen M, Yates E, Wang X, Maxwell CJ, Guan J. Trajectories of

health system use and survival for community-dwelling persons with dementia: a

population-based analysis from Ontario, Canada. Poster presentation, AcademyHealth

Annual Research Meeting, Boston, MA, June 26-28, 2016.

Mondor L, Maxwell CJ, Hogan DB, Bronskill SE, Gruneir A, Lane N, Wodchis WP. Impact of

multimorbidity on health-related quality of life in a population-based study of home care

clients with dementia in Ontario. Poster presentation, Campus Alberta Neuroscience 2016

International Conference: Promoting Healthy Brain Aging and Preventing Dementia,

Research and Translation. Banff, Alberta, May 24-27, 2016.

Campitelli M, Maxwell CJ, Austin P, Giannakeas V, Bronskill SE, on behalf of the FRAMING-LTC

Research Team. The variation of statin therapy among long-term care residents, physicians

and facilities in Ontario. Oral presentation, Canadian Association for Health Services &

Policy Research (CAHSPR) Conference, Toronto, Ontario, May 9-12, 2016.

Walker JD, Guan J, Vermeulen M, Yates E, Wang X, Maxwell CJ, Bronskill SE. Trajectories of

health system use and survival for community-dwelling persons with dementia: a

population-based analysis from Ontario, Canada. Oral presentation, Canadian Association

for Health Services & Policy Research (CAHSPR) Conference, Toronto, Ontario, May 9-

12, 2016.

Maclagan L, Guan J, Gandhi S, Maxwell CJ, Campitelli M, Gill SS, Daneman N, Seitz D, Hogan D,

Morris A, Bell CM, Bronskill SE. Exposure to potentially inappropriate medication among

long-term care residents with cognitive impairment in Ontario: Is there an association with

frailty? Oral presentation, Canadian Association for Health Services & Policy Research

(CAHSPR) Conference, Toronto, Ontario, May 9-12, 2016.

Thavorn K, Bai Y, Maxwell CJ, Gruneir A, Bronskill S, Kone Pefoyo A, Petrosyan Y, Wodchis W.

Multimorbidity and health system costs among older adults in Ontario, Canada. Oral

Presentation, 2nd Biennial Asia-Pacific Conference - Society for Medical Decision Making,

Hong Kong, Jan 8-10, 2016.

Strain LA, Maxwell C. Family Caregivers of Nursing Home Residents: Changes in Visiting and

Caregiver Well-being. Poster presentation, 68th Annual Scientific meeting of the

Gerontological Society of America, Orlando, Florida, Nov 21, 2015.


Iraniparast M, Dubin JA, Maxwell CJ, Tyas SL. The effect of apolipoprotein E-ԑ4 on the trajectory of

cognitive decline to dementia: A comprehensive review of the literature. Poster presentation,

Network for Aging Research (NAR) symposium, University of Waterloo, Waterloo, Ontario,

October 27, 2015.

Stock K, Hogan DB, Tyas S, Bronskill SE, Morris AM, Bell CM, Jeffs L, Maxwell CJ. The

identification of frailty and its role as an effect modifier of adverse drug-related outcomes

among assisted living residents. Oral presentation, 44th Annual Scientific & Educational

Meeting, Canadian Association on Gerontology, Calgary, AB, Oct 23-25, 2015. Abstract

published in C J Aging (TBA).

Pineau E, Hogan DB, Strain L, Amuah JE, Maxwell CJ. Correlates and outcomes of social

vulnerability among Assisted Living residents with and without dementia. Poster

presentation, 44th Annual Scientific & Educational Meeting, Canadian Association on

Gerontology, Calgary, AB, Oct 23-25, 2015. Abstract published in C J Aging (TBA).

Maxwell CJ, Bronskill SE, Diong C, Hogan DB, Patten SB, Jetté N, Marrie RA. Depressive symptom

trajectories in older adults with dementia and associated risk of functional decline. Poster

presentation, 8th Canadian Conference on Dementia, Ottawa, ON, Oct 1-3, 2015. Abstract

published in Can Geriatrics Journal 2015;18(4):254.

Maxwell CJ, Morris A, Bell CM, Bronskill SE, Jeffs L. Frailty and Recognizing Appropriate

Medications in Geriatrics and Long-Term Care [FRAMING-LTC]. Oral presentation, 3rd

Annual TVN Conference on improving care for frail elderly Canadians, Toronto, ON, Sept

27-29, 2015.

Stock K, Hogan DB, Patten SB, Bronskill SE, Gandhi S, Maxwell CJ, on behalf of the FRAMING-

LTC team. The coexistence of frailty, dementia and depression in older adults. Poster

presentation, 3rd Annual TVN Conference on improving care for frail elderly Canadians,

Toronto, ON, Sept 27-29, 2015.

Stock K, Hogan DB, Tyas SL, Bronskill SE, Morris AM, Bell CM, Jeffs L, Gandhi S, Maxwell CJ.

Frailty, drug use and hospitalization among older assisted living residents. Poster

presentation, 3rd Annual TVN Conference on improving care for frail elderly Canadians,

Toronto, ON, Sept 27-29, 2015.

Mainville C, Jeffs LP, Maione M, Zahradnik M, Morris A, Bell C, Bronskill S, Maxwell CJ, Tscheng

D, Sever L, Hyland S. Frailty and recognizing appropriate medications in geriatrics and

long term care [FRAMING-LTC]: Protocol. Poster presentation, 3rd Annual TVN

Conference on improving care for frail elderly Canadians, Toronto, ON, Sept 27-29, 2015.

Strain LA, Maxwell CJ. Well-being of family caregivers of assisted living: Changes over time. Oral

presentation, 5th International Conference on Health Wellness, and Society, Madrid, Spain,

Sept 3, 2015.

Maxwell CJ, Bronskill SE, Walker JD, Yates E, Gunraj N. Health system use, transitions to long-term

care and survival among community-dwelling older adults with dementia in Ontario,

Canada. Oral presentation, Alzheimer’s Association International Conference,

Washington, DC, July 19-23, 2015. Abstract published in Alzheimer’s & Dementia: The

Journal of the Alzheimer's Association 2015;11(7):p180.

Maxwell CJ, Bronskill SE, Diong C, Hogan DB, Patten SB, Jetté N, Marrie RA. Depressive symptom

trajectories in older adults with dementia and associated risk of functional decline. Poster

presentation, Alzheimer’s Association International Conference, Washington, DC, July 19-


23, 2015. Abstract published in Alzheimer’s & Dementia: The Journal of the Alzheimer's

Association 2015;11(7):p873.

Cepoiu-Martin M, Patten SB, Maxwell CJ, Tam-Tham H, Hogan DB. Predictors of

institutionalization in dementia – A systematic review and meta-analysis. Poster

presentation, Alzheimer’s Association International Conference, Washington, DC, July 19-

23, 2015. Abstract published in Alzheimer’s & Dementia: The Journal of the Alzheimer's

Association 2015;11(7):p342.

Gruneir A, Bronskill SE, Maxwell C, Bai Y, Kone A, Thavorn K, Petrosyan Y, Calvazara A, Wodchis

W. Individual demographics and continuity of care modified the association between

multimorbidity and hospitalization. Oral presentation, Academy Health 2015 Annual

Research Meeting, Minneapolis, MN, June 14-16, 2015.

Wodchis, W.P., Bai, Y., Thavorn, K., Petrosyan, Y., Lane, N.E., Bronskill, S., Maxwell, C., Gruneir,

A. & Kone, A. Comparative healthcare costs of 17 chronic conditions in Ontario. Oral

presentation, Canadian Association for Health Services and Policy Research Annual

Conference, 2015 May; Montreal, Canada.

Mondor L, Maxwell CJ, Bronskill SE, Grunier A, Wodchis WP. How Does Multimorbidity Affect

Health-Related Quality of Life in Ontario Home Care Clients? Oral presentation at the

2014 Canadian InterRAI Conference, Winnipeg, MB Canada. October 7, 2014.

Maxwell CJ, Amuah JE, Hogan DB, Cepoiu-Martin M, Gruneir A, Patten SB, Le Clair K, Wilson K,

Strain L. Acute care transitions and outcomes among assisted living residents with and

without dementia. Poster presentation, Alzheimer’s Association International Conference,

Copenhagen, Denmark, July 12-17, 2014. Abstract published in Alzheimer’s & Dementia:

The Journal of the Alzheimer's Association 2014 Vol. 10, Issue 4, Supplement, Pages P735-

6.

Maxwell CJ, Leah J, Bronskill SE, Hogan DB, Jetté N, Patten SB, Jantzi M, Heckman G, Hirdes JP.

The burden and correlates of persistent depressive symptoms among older home care

clients with dementia. Poster presentation, Alzheimer’s Association International

Conference, Copenhagen, Denmark, July 12-17, 2014. Abstract published in Alzheimer’s &

Dementia: The Journal of the Alzheimer's Association 2014 Vol. 10, Issue 4, Supplement,

Page P602.

Petrosyan Y, Wodchis W, Maxwell CJ, Bronskill SE, Kone A, Gruneir A, Thavorn K, Bai Y. Impact

of dementia on diabetes care quality in Ontario. Poster presentation, Alzheimer’s

Association International Conference, Copenhagen, Denmark, July 12-17, 2014. Abstract

published in Alzheimer’s & Dementia: The Journal of the Alzheimer's Association 2014

Vol. 10, Issue 4, Supplement, Page P313.

Marshall DA, Vanderby S, Frank C, Wasylak T, Mosher D, Noseworthy T, Maxwell C, MacDonald

K, Carter M. What Could the Future Hold? Simulating the Demand for Osteoarthritis (OA)

Care in Alberta to Plan a Sustainable OA Care System. Oral Presentation at the Health

Technology assessment International (HTAi) Annual Scientific Conference; Washington

DC, USA: June 14-18, 2014.

Lane NE, Maxwell CJ, Bronskill SE, Wodchis WP. Does socioeconomic status moderate the effect of

increasing chronic disease burden on three-year survival in a population-based cohort?

Oral presentation, 2014 Geriatric Medicine Combined Research Day, 2014 June 20

Toronto, Canada.


Lane NE, Maxwell CJ, Gruneir A, Bronskill SE, Wodchis WP. Does socioeconomic status moderate

the effect of increasing chronic disease burden on three-year survival in a population-based

cohort? Oral presentation, AcademyHealth Annual General Meeting, 2014 June 6, San

Diego, United States of America.

Lane NE, Maxwell CJ, Gruneir A, Bronskill SE, Wodchis WP. Does socioeconomic status moderate

the effect of increasing chronic disease burden on three-year survival in a population-based

cohort? Poster presentation, AcademyHealth Annual General Meeting, 2014 June 9, San

Diego, United States of America.

Lane N, Maxwell CJ, Gruneir A, Bronskill SE, Wodchis W. Does socioeconomic status moderate the

effect of increasing chronic disease burden on three-year survival in a population-based

cohort? Poster presentation at the Canadian Association for Health Services and Policy

Research (CAHSPR), Toronto, ON, May 12-15, 2014. [Winner of 1st Prize, Poster

Competition].

Petrosyan Y, Wodchis W, Bronskill S, Kone A, Gruneir A, Thavorn K, Maxwell CJ, Bai Y. The

comorbidity pattern and the quality of diabetes care in Ontario. Poster panel presentation at

the Canadian Association for Health Services and Policy Research (CAHSPR), Toronto,

ON, May 12-15, 2014.

Reynolds S, Wodchis W, Bronskill S, Maxwell CJ. A comparative analysis of long-term care policies

and placements. Poster presentation at the Canadian Association for Health Services and

Policy Research (CAHSPR), Toronto, ON, May 12-15, 2014.


K, Carter M. What could the future hold? Simulating the demand for Osteoarthritis (OA)

care in Alberta to plan a sustainable OA care system. Poster presentation at the Canadian

Association for Health Services and Policy Research (CAHSPR), Toronto, ON, May 12-15,

2014.


K, Carter M. What Could the Future Hold? Simulating the Demand for Osteoarthritis (OA)

Care in Alberta to Plan a Sustainable OA Care System. Poster presentation at the

Osteoarthritis Research Society International (OARSI) World Congress; Paris, France:

April 24-27, 2014.


KV, Carter M. What could the future hold? Simulating the demand for osteoarthritis (OA)

care in Alberta to plan a sustainable OA care system. Published abstract in Osteoarthritis

and Cartilage. 2014; 22 (supplement): S214-S215.

Strain L, Maxwell C. Far and farther: adult children caring long-distance for parents in care settings.

Oral presentation, 42nd Annual Scientific & Educational Meeting, Canadian Association on

Gerontology, Halifax, NS, Oct 17-19, 2013.

Maxwell CJ, Vu M, Hogan DB, Patten SB, Jettė N, Bronskill SE, Kergoat MJ, Heckman G, Hirdes

JP. Correlates of neuropsychiatric symptoms among older women and men with dementia

across continuing care settings. Poster presentation at the 7th Canadian Conference on

Dementia, Vancouver, BC, October 3-5, 2013.

Maxwell CJ, Zehr M, Vu M, Hogan DB, Patten SB, Jettė N, Bronskill SE, Kergoat MJ, Heckman G,

Danilla OM, Hirdes JP. Neuropsychiatric symptoms in dementia: Variation by care setting

and gender. Poster presentation, Alzheimer’s Association International Conference, Boston


MA, July 15-18, 2013. Abstract published in Alzheimer’s & Dementia: The Journal of the

Alzheimer's Association Vol. 9, Issue 4, Supplement, Page P758.

Gruneir A, Bronskill SE, Maxwell CJ, Konė A, Petrosyan Y, Bai Y, Wodchis W. Multimorbidity and

hospitalization outcomes over one year. Poster panel presentation at the Canadian

Association for Health Services and Policy Research, Vancouver, BC, May 28-31, 2013.

Konė A, Calzavara A, Bai Y, Bronskill SE, Gruneir A, Thavorn K, Maxwell CJ, Wodchis W.

Prevalence and Characteristics of Multimorbidity in Ontario. Poster panel presentation at

the Canadian Association for Health Services and Policy Research, Vancouver, BC, May

28-31, 2013.

Thavorn K, Wodchis W, Maxwell CJ, Konė A, Gruneir A, Bronskill SE, Petrosyan Y, Bai Y.

Economic burden of Multimorbidity in Ontario’s Health Care System. Poster panel

presentation at the Canadian Association for Health Services and Policy Research,

Vancouver, BC, May 28-31, 2013.

Petrosyan Y, Wodchis W, Bronskill SE, Konė A, Gruneir A, Thavorn K, Maxwell CJ, Bai Y. The

impact of comorbid conditions on the quality of diabetes care in Ontario. Poster panel

presentation at the Canadian Association for Health Services and Policy Research,

Vancouver, BC, May 28-31, 2013.

Bansal S, Giangregorio LM, Maxwell CJ, Papaioannou A, Jette N, and Hirdes JP. Risk Factors for

Falls in Ambulatory Home Care Clients with Parkinson’s Disease. Presented as a poster at

the 2013 Annual Scientific Meeting of the American Geriatrics Society May 4, 2013.

Grapevine, TX. Abstract published in Journal of the American Geriatrics Society 2013;61

Suppl 1:s211.

Marshall DA, Vanderby S, Frank C, Enns E, Kulin N, Wasylak T, Mosher D, Noseworthy T, Rogers

P, Maxwell C, Rohleder T, Pykerman K, Carter M. Simulation modeling with system

dynamics (SD) to plan osteoarthritis care delivery in Alberta. Published abstract in

Osteoarthritis and Cartilage. 2013; 21(supplement): S167-S168.

Marshall DA, Vanderby S, Frank C, Enns E, Kulin N, Wasylak T, Mosher D, Noseworthy T, Rogers

P, Maxwell C, Rohleder T, Pykerman K, Carter M. Simulation modeling with system

dynamics (SD) to plan osteoarthritis care delivery in Alberta. Osteoarthritis Research

Society International (OARSI) World Congress on Osteoarthritis; Philadelphia, PA: April

18-21, 2013. (Poster presentation).

Jetté N, Pringsheim T, Day L, De Robles P, Fiest K, Hamilton M, Hogan DB, Korngut L, Kwon CS,

Lam D, Mah J, Marrie RA, Maxwell C, Metcalfe A, Oskoui M, Patten SB, Pearson D, Reid

A, Smith E, Steeves T, Svenson L, Wiebe and Dykeman J. The international incidence and

prevalence of neurological diseases. Do we really know how common neurological

conditions are? Challenges in interpreting international epidemiological studies. American

Academy of Neurology (San Diego, CA) March 2013 (oral and poster presentations).

Marshall D, Vanderby S, Enns E, Frank C, Wasylak T, Mosher DP, Noseworthy T, Rogers P,

Maxwell C, Sundaram A, Carter M. Simulation modeling with system dynamics (SD) using

real-world observational data to plan osteoarthritis care delivery in Alberta [published

abstract PMS89]. Value in Health. 2012; 15(4): A34.

Marshall D, Enns E, Vanderby S, Frank C, Maxwell C, Wasylak T, Mosher DP, Barnabe C,

Noseworthy T. Building a Decision Support Tool for Delivery of Health Services for

Patients with Hip and Knee Osteoarthritis. Oral presentation at the International Society on


Priorities in Health Care (ISPHC; Priorities 2012); Vancouver, British Columbia, Canada:

September 16-19, 2012.

Marshall D, Vanderby S, Enns E, Frank C, Wasylak T, Mosher DP, Noseworthy T, Rogers P,

Maxwell C, Sundaram A, Carter M. Simulation modeling with system dynamics (SD) using

real-world observational data to plan osteoarthritis care delivery in Alberta. Poster

presentation at the International Society for Pharmacoeconomics and Outcomes Research

(ISPOR); Washington, D.C., USA: June 4-6, 2012.

Fiest KM, Dykeman J, Patten SB, Wiebe S, Kaplan GG, Maxwell CJ, Bulloch AGM, Jetté N.

Depression in Epilepsy: A Systematic Review and Meta-Analysis. Presented at the

Canadian League Against Epilepsy Annual Meeting, Calgary, AB, October 2012.

Maxwell CJ, Amuah J, Cepoiu-Martin M, Soo A, Gruneir A, Hogan D, Patten S, LeClair K, Wilson

K, Strain L, for the ACCES-Mental Health Research Group. Resident and facility

predictors of hospitalization among older adults with dementia residing in assisted living

facilities. Oral presentation, Canadian Coalition for Seniors’ Mental Health & Canadian

Academy of Geriatric Psychiatry 2012 Joint Conference, Banff, AB, Sept 21-22, 2012.

Maxwell CJ, Bronskill S, Leah J, Jetté N, Hogan D, Patten S, Heckman G, Jantzi M, Hirdes J, on

behalf of the ideasPNC research team. The course of depressive symptoms and associated

factors among older home care clients. Oral presentation, Canadian Coalition for Seniors’

Mental Health & Canadian Academy of Geriatric Psychiatry 2012 Joint Conference, Banff,

AB, Sept 21-22, 2012.

Vu M, Hogan DB, Jetté N, Bronskill S, Heckman G, Patten SB, Chen J, Hirdes JP, Maxwell CJ, on

behalf of the ideasPNC research team. A population-based study of home care clients with

dementia in Ontario. Poster presentation, Canadian Coalition for Seniors’ Mental Health &

Canadian Academy of Geriatric Psychiatry 2012 Joint Conference, Banff, AB, Sept 21-22,

2012.

Strain LA, Maxwell CJ. Families caring for assisted living and nursing home residents with dementia:

Does setting matter? Oral presentation, International Sociological Association’s Second

Forum of Sociology, Buenos Aires, Argentina, August 1-4, 2012.

Maxwell CJ, Amuah J, Cepoiu-Martin M, Soo A, Gruneir A, Hogan D, Patten S, LeClair K, Wilson

K, Strain L. Resident and facility predictors of hospitalization among older adults with

dementia residing in assisted living facilities. Oral presentation, Alzheimer’s Association

International Conference, Vancouver, BC, July 14-19, 2012. Abstract published in

Alzheimer’s & Dementia 2012;8(4) Suppl. P429.

Cepoiu-Martin M, Strain L, Soo A, Hogan D, Patten S, Gruneir A, LeClair K, Wilson K, Amuah J,

Maxwell CJ. Resident and facility determinants of long-term care placement among older

adults with dementia residing in assisted living facilities. Oral presentation, Alzheimer’s

Association International Conference, Vancouver, BC, July 14-19, 2012. Abstract

published in Alzheimer’s & Dementia 2012;8(4) Suppl. P251.

Cepoiu-Martin M, Tam H, Maxwell CJ, Drummond N, Ronksley P, Hemmelgarn B. The effect of

dementia case-management in community-dwelling individuals with dementia on resource

utilization: A systematic review and meta-analysis. Poster presentation, Alzheimer’s

Association International Conference, Vancouver, BC, July 14-19, 2012. Abstract

published in Alzheimer’s & Dementia 2012;8(4) Suppl. P567.

Roberts JI, Maxwell C, Roach P, Fiest K, Hogan D, Dykeman J, Day L, Pearson D, Cohen A, Smith

E, Venges-Torres A, Steeves T, Pringsheim T and Jetté N. The incidence and prevalence of


dementia – a systematic review and meta-analysis. Canadian Journal of Neurological

Sciences Conference: 47th Annual Congress of the Canadian Neurological Sciences

Federation Ottawa, ON Canada. Conference Start: 20120605 Conference End: 20120608.

Abstract published in Can J Neurol Sci, 39 (3 SUPPL. 3): S42-S43.

Maxwell CJ, Soo A, Strain LA, Hogan DB, Patten SB, Cepoiu-Martin M, Gruneir A, Le Clair K,

Wilson K, Amuah JE, on behalf of the ACCES-Mental Health Research Group. Factors

associated with long term care placement among older adults with dementia residing in

Assisted Living facilities. Poster presented at the 6th Canadian Conference on Dementia,

Montreal QC, Oct 27-29, 2011.

Hogan DB, Donaldson EE, Charlton AM, Pearson DM, Quickfall J, Cohen AF, Patry D, Maxwell CJ,

Smith EE. The evolving profile of patients seen in a Canadian dementia clinic. Poster

presented at the 6th Canadian Conference on Dementia, Montreal QC, Oct 27-29, 2011.

Donaldson E, Charlton A, Fischer K, Pearson DM, Quickfall J, Cohen AF, Patry D, Maxwell CJ,

Hogan DB, Smith EE. A prospective clinic-based research registry for persons with

cognitive symptoms. Poster presented at the 6th Canadian Conference on Dementia,

Montreal QC, Oct 27-29, 2011.

Maxwell CJ, Strain LA, Hogan D, Patten S, Wanless D, Gilbart E, Cepoiu-Martin M, on behalf of the

ACCES-Mental Health Group. Dementia and Depression in Continuing Care Settings in

Alberta: Priority Issues for Care and Policy. Poster Presentation (and winner Best Poster

by Operating Grant Participant) at the Found in Translation Conference: Sharing Alberta

Research for Mental Wellness in Seniors and Persons with Disabilities. Part of the

Collaborative Research Grant Initiative: Mental Wellness in Seniors and Persons with

Disabilities, Edmonton, AB, April 18, 2011.

Maxwell CJ, Strain LA, Soo A, Gilbart E, Wanless D, Hogan DB, Wodchis W, Amuah JE, on behalf

of the ACCES Research Group. Factors associated with long term care placement among

residents of assisted living facilities. Oral Presentation at the Canadian Geriatrics Society

31st Annual Scientific Meeting, Vancouver, BC, April 14-16. 2011.

Freiheit EA, Hogan DB, Strain LA, Schmaltz HN, Patten SB, Eliasziw M, Maxwell CJ.

Operationalizing frailty among older residents of assisted living facilities. Oral Presentation

at the Canadian Geriatrics Society 31st Annual Scientific Meeting, Vancouver, BC, April

14-16. 2011. (E. Freiheit was awarded the Edmund V. Cowdry Prize for best oral

presentation by a graduate student).

Maxwell CJ, Freiheit E, Hogan DB, Strain LA, Schmaltz HN, Patten SB, Eliasziw M.

Operationalizing Frailty among Older Residents of Assisted Living Facilities. Oral

Presentation – 2010 Canadian interRAI Conference, Toronto, ON, Oct 4-6, 2010.

Maxwell CJ, Gilbart E, Strain LA, Wanless D, Soo A, Wodchis W, Teare G, Hogan D, Eliasziw M.

Factors Predicting Discharge to LTC among Residents in Alberta Assisted Living

Facilities. Oral Presentation – 2010 Canadian interRAI Conference, Toronto, ON, Oct 4-6,

2010.

Maxwell CJ, Strain LA, Wodchis W, Soo A., Gilbart E, Hogan D, Teare G, Wanless D, Eliasziw M.

Assisted Living in the continuum of continuing care in Canada: Implications for the health

and well-being of residents and their family members. Oral Presentation at the First

International Conference on Evidence-based Policy in Long-term Care, Personal Social

Services Research Unit, London School of Economics & Political Science, London, UK,

Sept 10, 2010.


Freiheit E, Hogan DB, Eliasziw M, Meekes MF, Ghali W, Maxwell CJ. A frailty index for older

cardiovascular patients consisting of physical, cognitive, emotional and social domains.

Presented at the Gerontological Society of America 62nd Annual Scientific Meeting,

Atlanta, GA, Nov 18-22, 2009. Abstract published in Gerontologist 2009;49:499.

Foebel A, Hirdes J, Heckman G, Tjam E, Tyas S, Maxwell CJ. Heart failure medication use in older

home care clients. (Poster Presentation). Presented at the 25th International Conference on

Pharmacoepidemiology and Therapeutic Risk Management, Providence, RI, Aug 16-19,

2009. Abstract published in Pharmacoepidemiology and Drug Safety 2009;18: S129,

Abstract #295.

Supina AL, Hogan DB, Patten SB, Manns BJ, Downey W, Beck P, Maxwell CJ. The risk of

institutionalization with the concurrent use of cholinesterase inhibitors (ChEIs) and

potentially contraindicated medications in Alzheimer's disease (Poster Presentation).

Presented at the 25th International Conference on Pharmacoepidemiology and Therapeutic

Risk Management, Providence, RI, Aug 16-19, 2009. Abstract published in

Pharmacoepidemiology and Drug Safety 2009;18: S86, Abstract #202.

Foebel AD, Hirdes JP, Heckman GA, Tjam EY, Tyas SL, Maxwell CA. A Role for Home Care in

Improving Heart Failure Management. Plenary Presentation, Ontario Home Care

Association Symposium, Toronto ON, May 28, 2009.

Maxwell CJ, Jantzi M, Poss J, Wodchis W, Hogan D, Supina A, Lynd L, Marra C, Hirdes JP.

Construct validity of an observed health-related quality of life (HRQL) measure in

Alzheimer's disease. (Oral Presentation) presented at the 15th Annual Conference of the

International Society for Quality of Life Research, Montevideo Uruguay, Oct 22-25, 2008.

Abstract published in Quality of Life Research 2008;A-13, Abstract #1504

[www.isoqol.org/2008_conference/meeting_abstract.htm].

King KM, Kang J, Currie G, Tsuyuki RT, Johnson JA, Maxwell CJ. Predictors of women’s health-

related quality of life (HRQL) following cardiac surgery. Poster presentation at the 15th

Annual Conference of the International Society for Quality of Life Research, Montevideo

Uruguay, Oct 22-25, 2008. Abstract published in Quality of Life Research 2008;A-69,

Abstract #116/1500 [www.isoqol.org/2008_conference/meeting_abstract.htm].

Supina AL, Hogan DB, Patten SB, Manns BJ, Downey W, Beck P, Maxwell CJ. “The Impact on

Prevalence of Various Definitions for Co-Medication Use of Cholinesterase Inhibitors and

Potentially Contraindicated Medications in Alzheimer’s Disease”, (poster presentation),

presented at the 24th International Conference on Pharmacoepidemiology & Therapeutic Risk

Management, Copenhagen, Denmark, Aug 17-20, 2008. Abstract published in

Pharmacoepidemiology and Drug Safety 2008;17 : S54.

Amuah JE, Hogan DB, Eliasziw M, Supina A, Beck P, Downey W, Maxwell CJ. “Factors Predictive

of Institutionalization in a Population-Based Cohort of Alzheimer's disease Patients

Dispensed Cholinesterase Inhibitors”, (poster presentation), presented at the 24th

International Conference on Pharmacoepidemiology & Therapeutic Risk Management,

Copenhagen, Denmark, Aug 17-20, 2008. Abstract published in Pharmacoepidemiology and

Drug Safety 2008;17 : S193.

Giangregorio LM, Papaioannou A, Hirdes J, Maxwell CJ, Jantzi M, Poss JW. Predictors of

Osteoporosis Management among Residents Living In Long-Term Care. American Society

for Bone and Mineral Research 30th Annual Meeting, Montreal, Sept 12-16 2008, Abstract

#741, Presentation #Sa368.

http://www.isoqol.org/2008_conference/meeting_abstract.htm

http://www.isoqol.org/2008_conference/meeting_abstract.htm


Supina AL, Hogan DB, Patten SB, Amuah JE, Downey W., Beck, P Maxwell CJ. “The Risk of Death

with Concurrent Use of Cholinesterase Inhibitors and Anticholinergics/ Antipsychotics in

Alzheimer’s Disease”, (oral presentation), presented at the 23nd International Conference on

Pharmacoepidemiology & Therapeutic Risk Management, Quebec City, QC, Aug 18-22,

2007. Abstract published in Pharmacoepidemiology and Drug Safety 2007;16 (S2): S30.

Amuah JE, Hogan, D. B., Eliasziw, M., Supina A, Maxwell C. J., Downey W., Beck, P. “Persistence

of Cholinesterase Inhibitor Therapy in a Population-based Cohort of Patients with

Alzheimer's disease”, (poster presentation), presented at the 23nd International Conference on

Pharmacoepidemiology & Therapeutic Risk Management, Quebec City, QC, Aug 18-22,

2007. Abstract published in Pharmacoepidemiology and Drug Safety 2007;16 (S2): S470.

Hirdes JP, Fletcher PC, Berg KO, Maxwell CJ. “Use of the interRAI HC assessment instrument for

health promotion and health education with home care clients”, (oral symposium

presentation), presented at the 19th IUHPE (International Union for Health Promotion &

Education) Conference on Health Promotion & Health Education, Vancouver BC, June 10-

15, 2007

Strain LA, Wanless D, Maxwell CJ. “Family support for frail older adults in residential care settings”,

(oral presentation), presented at the International Conference on Sociology, Athens Institute

for Education & Research (ATINER), Athens, Greece, May 2007.

Maxwell CJ, Vik SA, Jantzi M, Poss J, Hirdes JP, Hanley DA, Hogan DB. “Factors associated with

the pharmacological treatment of osteoporosis in an older home care population”, (oral

presentation), presented at the Canadian CIHI/RAI Conference 2007: Making the Health Care

Connection – Sharing and Caring Beyond Borders, Ottawa ON, May 2-4, 2007.

Teare G, Walker JD, Hogan DB, Lewis S, Maxwell CJ. “Correlates of hospitalization and potentially

avoidable hospitalization among residents of complex care”, (oral presentation), presented at

the Canadian CIHI/RAI Conference 2007: Making the Health Care Connection – Sharing and

Caring Beyond Borders, Ottawa ON, May 2-4, 2007.

Jantzi M, Maxwell CJ. “Use of cholinesterase inhibitors among Ontario home care clients”, (poster

presentation), presented at the Canadian CIHI/RAI Conference 2007: Making the Health Care

Connection – Sharing and Caring Beyond Borders, Ottawa ON, May 2-4, 2007.

Supina AL, Hogan DB, Amuah JE, Downey W, Beck P, Maxwell CJ. “The concurrent use of

cholinesterase inhibitors and anticholinergic medications in patients with Alzheimer’s

disease: A comparison of Alberta & Saskatchewan”, (poster presentation), presented at the

2007 Canadian Agency for Drugs and Technologies in Health (CADTH) Invitational

Symposium, Ottawa ON, April 23-24, 2007.

Supina AL, Hogan DB, Amuah JE, Downey W, Beck P, Maxwell CJ. “Comparison of demographic,

clinical and pharmacotherapeutic characteristics of patients with Alzheimer’s disease

receiving cholinesterase inhibitors in Saskatchewan to patients of cholinesterase inhibitor

clinical trials”, presented at the Annual Scientific Meeting of the Canadian Geriatrics Society,

Banff AB, April 19-21, 2007. Abstract published in The Canadian Journal of Geriatrics

2007;10(1):7.

Amuah JE, Hogan DB, Eliasziw M, Supina A, Maxwell CJ, Downey W, Beck, P. "Cholinesterase

Inhibitors and All-Cause Mortality in a Population-Based Cohort of Patients with Alzheimer's

Disease", (poster presentation) presented at the 8TH International Conference AD/PD 2007,

Salzburg, Austria, March 14-18, 2007. Abstract published in Neurodegenerative Diseases

2007; 4(Suppl 1):129.


Amankwah E, Quan H, Campbell N, Maxwell C, Onysko J. “Hypertensives without regular

physicians are under-treated”, (poster presentation) presented at the Annual Canadian

Cardiovascular Congress, Vancouver BC, Oct 21-25, 2006. Abstract published in the

Canadian Journal of Cardiology 2006;22 Suppl D:113D.

Maxwell CJ, Kang J, Walker JD, Zhang JX, Hogan DB, Feeny D, Wodchis W. “Social and clinical

correlates of health-related quality of life in frail community-based seniors”, (poster

presentation) presented at the 13th Annual Conference of the International Society for Quality

of Life Research, Lisbon Portugal, Oct 10-14, 2006. Abstract published in Quality of Life

Research 2006;Dec (suppl. 1)[www.isoqol.org/2006mtgabstracts].: A-139.

Supina A, Amuah JE, Maxwell CJ, Hogan DB. “The concurrent use of cholinesterase inhibitors and

contraindicated medications in patients with Alzheimer’s disease”, presented at the 22nd

International Conference on Pharmacoepidemiology and Therapeutic Risk Management,

Lisbon, Portugal, Aug 24-27, 2006. Abstract published in Pharmacoepidemiology & Drug

Safety 2006;15(S!): S55.

Strain LA, Maxwell CJ. “Assisted living in Alberta Canada: Where does it fit on the continuum of

aged care?” (oral presentation), presented at the XVI International Sociological Association

World Congress of Sociology, Durban, South Africa, July 2006.

Maxwell CJ, Onysko J, Eliasziw M, Zhang JX, Campbell NRC, Johansen H. “Trends in the diagnosis

and treatment of hypertension in Canada”, (poster presentation) presented at the Annual

Conference of the Canadian Association for Population Therapeutics and the 3rd Canadian

Therapeutics Congress, Toronto ON, May 10-13, 2006. Abstract published in the Canadian

Journal of Clinical Pharmacology 2006;13(1):e185.

Maxwell CJ, Supina A, Hogan DB, Amuah J, Silvius J, Eliasziw M. “Demographic and clinical

characteristics of patients with Alzheimer’s disease receiving cholinesterase inhibitors”,

(poster presentation) presented at the Annual Conference of the Canadian Association for

Population Therapeutics and the 3rd Canadian Therapeutics Congress, Toronto ON, May 10-

13, 2006. Abstract published in the Canadian Journal of Clinical Pharmacology

2006;13(1):e150.

Lewis S, Southern DA, Maxwell CJ, Dunn JR, Noseworthy TW, Ghali WA. “Americans living in

Canada and their comparative views of the American and Canadian health care systems”,

presented at the annual meeting of the Society of General Internal Medicine, Los Angeles

April 2006. Abstract published in the Journal of General Internal Medicine 2006;21(suppl

4):10.

Southern DA, Lewis S, Maxwell CJ, Dunn JR, Noseworthy TW, Corbett G, Thomas K, Ghali WA.

“Sampling ‘hard-to-reach’ populations in health research: Yield from a study targeting

Americans living in Canada”, presented at the annual meeting of the Society of General

Internal Medicine, Los Angeles April 2006. Abstract published in the Journal of General

Internal Medicine 2006;21(suppl 4):128.

Maxwell CJ, Hogan DB, Schmaltz H, Hepple R, Patten SB, Strain L, Yong W, Parboosingh J,

Rolfson D, Eliasziw M. “Frailty, inflammatory mechanisms and adverse health outcomes

among vulnerable seniors residing in the community”, (poster presentation), presented at the

2nd International Working Meeting on Frailty and Aging, Montreal QC, March 16-18, 2006.

Maxwell CJ, Supina A, Hogan DB, Amuah JE, Silvius J, Eliasziw M. “Demographic and clinical

characteristics of patients with Alzheimer’s disease who were prescribed donepezil and

rivastigmine in Saskatchewan”, (poster presentation), presented at the 18th Annual Centre for


Health Services and Policy Research (CHSPR) Health Policy Conference, Vancouver BC,

Feb 9-10, 2006.

Wang J, Keown LA, Patten SB, Williams JVA, Currie SR, Beck CA, Maxwell CJ, El-Guebaly NA.

“Ways for dealing with daily stress: the differences between healthy people and individuals

with mental or physical illnesses”, (oral presentation) presented at the Global Perspectives on

Chronic Disease Management: The Calgary Conference, Calgary AB, Sept 26-29, 2005.

Supina AL, Johnson JA, Maxwell CJ, Patten SB, Williams JVA. The usefulness of the EQ-5D in

differentiating among persons with and without major depressive episode and anxiety. Poster

presented at the 22nd Annual Plenary Meeting of the EuroQol Group, Oslo, Norway, Sept 8-

10, 2005.

Maxwell CJ, Jelinski SE, Ghali WA, Parsons GA, King K, Piket M, Southern D. “Living alone and

health outcomes following acute myocardial infarction”, (poster presentation) presented at the

6th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease

and Stroke, Washington DC, May 14-16, 2005. Abstract published in Circulation 2005;

111(20):e344.

Galbraith PD, Larsen ET, Maxwell CJ, Schopflocher DP, Svenson LW, Ghali WA. “Troponinitis

without an accompanying myocardial infarction code”, (poster presentation) presented at the

6th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease

and Stroke, Washington DC, May 14-16, 2005. Abstract published in Circulation 2005;

111(20):e340.

Maxwell CJ, Roberts M, Poss J, Hirdes JP, Hanley D, Vik SA, Hogan DB. “Continued evidence for

the suboptimal treatment of osteoporosis among older adults”, (oral presentation) presented at

the Annual Conference of the Canadian Association for Population Therapeutics and the 2nd

Canadian Therapeutics Congress, Vancouver BC, April 13-19, 2005. Abstract published in

The Canadian Journal of Clinical Pharmacology 2005;12 (1):e43.

Beck CA, Patten SB, Williams JVA, Wang J, El-Guebaly N, Currie S, Maxwell CJ. “Psychotropic

drug utilization in Canada”, (poster presentation) presented at the Annual Conference of the

Canadian Association for Population Therapeutics and the 2nd Canadian Therapeutics

Congress, Vancouver BC, April 13-19, 2005. Abstract published in The Canadian Journal of

Clinical Pharmacology 2005;12 (1):e93.

Supina AL, Maxwell CJ, Johnson JA, Patten SB, Williams J. “The usefulness of the EQ-5D in

differentiating persons with and without major depressive episode and, by treatment

adequacy”, (poster presentation) presented at the Annual Conference of the Canadian

Association for Population Therapeutics and the 2nd Canadian Therapeutics Congress,

Vancouver BC, April 13-19, 2005. Abstract published in The Canadian Journal of Clinical

Pharmacology 2005;12 (1):e103.

Maxwell CJ, Strain LA. “Continuing care reform: Implications for the balance and quality of care for

frail older Canadians”, (oral presentation) presented at the Annual Meeting of the Canadian

RAI Research Group, Canadian Collaborating Centre for interRAI, Banff AB, March 12-14,

2005.

Walker JD, Maxwell CJ, Teare G, Lewis S, Hogan DB. “Potentially avoidable hospitalizations in

institutionalized older persons”, (oral presentation) presented at the Annual Meeting of the

Canadian RAI Research Group, Canadian Collaborating Centre for interRAI, Banff AB,

March 12-14, 2005.


Maxwell CJ, Roberts M, Poss J, Hirdes JP, Hanley D, Vik SA, Hogan DB. “Continued evidence for

the suboptimal treatment of osteoporosis among older adults”, (oral presentation) presented at

the Annual Meeting of the Canadian RAI Research Group, Canadian Collaborating Centre for

interRAI, Banff AB, March 12-14, 2005.

Beck CA, Williams JVA, Currie SR, Wang J, Maxwell CJ, El-Guebaly N, Patten SB. Antidepressant

utilization in Canada. Canadian Academy of Psychiatric Epidemiologists Annual Scientific

Symposium. Montreal, October 14, 2004.

Currie SR, Patten SB, Williams JVA, Wang J, Maxwell CJ, Beck CA, El-Guebaly N. Comorbidity of

major depression with substance use disorders. Canadian Academy of Psychiatric

Epidemiologists Annual Scientific Symposium. Montreal, October 14, 2004.

Wang J, Patten SB, Williams JVA, Currie SR, Beck CA, Maxwell CJ, El-Guebaly N. Help-seeking in

individuals with mood disorders: preliminary findings from the CCHS 1.2. Canadian

Academy of Psychiatric Epidemiologists Annual Scientific Symposium. Montreal, October

14, 2004.

Victorino CC, Maxwell CJ, Dalby DM, Hirdes JP, Hogan DB, Patten SB. “The Prevalence and

Management of Pain among Older Home Care Clients”, (oral presentation) presented at the

2nd International Conference on Therapeutic Risk Management and 20th International

Conference on Pharmacoepidemiology, Bordeaux, France, 22-25 August, 2004. Abstract

published in Pharmacoepidemiology and Drug Safety 2004;13(suppl. 1):S253.

Maxwell CJ, Hogan DB, Basran J, Ebly E, Zhang J. “Medications with anticholinergic effects and

adverse health outcomes among older persons”, (oral presentation) presented at the Annual

Conference of the Canadian Association for Population Therapeutics and the 1st Canadian

Therapeutics Congress, Winnipeg MN, June 2004. Abstract published in The Canadian


Victorino C, Vik SA, Maxwell CJ, Hogan DB, Patten SB. “Pain management among older home care

clients”, (poster presentation) presented at the Annual Conference of the Canadian

Association for Population Therapeutics and the 1st Canadian Therapeutics Congress,

Winnipeg MN, June 2004. Abstract published in The Canadian Journal of Clinical

Pharmacology 2004;11(1):e116.

Vik SA, Maxwell CJ, Hogan DB. “Use of natural medicines in an older home care population:

complementary or alternative therapy?” (poster presentation) presented at the Annual

Conference of the Canadian Association for Population Therapeutics and the 1st Canadian

Therapeutics Congress, Winnipeg MN, June 2004. Abstract published in The Canadian


Walker JD, Zhang JX, Maxwell CJ, Wodchis WP, Venturini A, Hogan DB, Feeny DH. “Measuring

declines in health-related quality of life in older persons”, (poster presentation) presented at

the ISOQOL Symposium, Boston MA, June 27, 2004. Conference Proceedings (abstract

#179).

Zhang JX, Walker JD, Maxwell CJ, Wodchis WP, Venturini A, Hogan DB, Feeny DH. “A

comparison of changes in observed and self-reported HRQL in community-based seniors”,

(poster presentation) presented at the ISOQOL Symposium, Boston MA, June 27, 2004.

Conference Proceedings (abstract #180).

Maxwell CJ, Walker JD, Wodchis WP, Venturini A, Zhang JX, Hogan DB, Feeny DH. “A

Comparison of Observed and Self-Reported Health-Related Quality of Life in a Home Care

Population”, (poster presentation) presented at the 10th Annual Conference of the


International Society for Quality of Life Research, Prague Czech Republic, Nov 12-15, 2003.

Abstract published in Quality of Life Research 2003;12:782.

Walker JD, Maxwell CJ, Wodchis WP, Venturini A, Zhang JX, Hogan DB, Feeny DH. “Correlates of

Health-Related Quality of Life in the Community-Based Elderly”, (poster presentation)

presented at the 10th Annual Conference of the International Society for Quality of Life

Research, Prague Czech Republic, Nov 12-15, 2003. Abstract published in Quality of Life

Research 2003;12:850.

Walker JD, Maxwell CJ, Wodchis WP, Zhang JX, Hogan DB, Feeny DH. “Correlates of Health-

Related Quality of Life in Community-Based Frail Elderly”, (oral presentation) presented at

the Second Joint U.S. & Canadian Case Mix and Quality Assurance Conference, Victoria BC,

September 10-14, 2003.

Jelinski SE, Maxwell CJ, Ghali WA, Parsons GA. “An Evaluation of Pharmacotherapy and Outcomes

Following Acute Myocardial Infarction in Male and Female Patients”, presented at the 1st

International Conference on Therapeutic Risk Management & 19th International Conference

on Pharmacoepidemiology, Philadelphia PA, 21-24 August, 2003. Abstract published in

Pharmacoepidemiology and Drug Safety 2003;12(suppl. 1):S118.

Maxwell CJ, Hicks MS, Hogan DB, Basran J, Ebly EM. “Supplemental Use of Antioxidant Vitamins

and Subsequent Risk of Cognitive Decline and Dementia”, (oral presentation) presented at the

1st International Conference on Therapeutic Risk Management and 19th International

Conference on Pharmacoepidemiology, Philadelphia PA, 21-24 August, 2003. Abstract

published in Pharmacoepidemiology and Drug Safety 2003;12(suppl. 1):S145.

Wodchis WP, Maxwell CJ, Venturini A, Walker J, Zhang JX, Hogan DB, Feeny DH. “A comparison

of observed and self-reported health-related quality of life in a home care population”, (oral

presentation) presented at the Vth European Congress of Gerontology (IAG~European

Region), Barcelona, July 2003. Abstract published in Rev Esp Geriatr Gerontol 2003;38(Supl

1):46.

Maxwell CJ, Wodchis WP, Walker J, Venturini A, Zhang JX, Hogan DB, Feeny DH. “A cross-

national study of self-reported health-related quality of life among elderly home care clients”,

(poster presentation) presented at the Vth European Congress of Gerontology (IAG~European

Region), Barcelona, July 2003. Abstract published in Rev Esp Geriatr Gerontol 2003;38(Supl

1):118.

Maxwell CJ, Jelinski SE, Ghali WA, Parsons GA. “A Comparison of Outcomes Following Acute

Myocardial Infarction among Women and Men in Calgary Alberta”, (oral presentation)

presented at the Annual Conference of the Canadian Association for Population Therapeutics,

Quebec City QC, March 2003. Abstract published in The Canadian Journal of Clinical

Pharmacology 2003;10(1):22.

Hirdes JP, Dalby D, Maxwell CJ, Patten SB, Hogan DB, Beck C, Rabinowitz T. “The Prevalence and

Management of Depression among Elderly Home Care Clients in Ontario”, (oral

presentation) presented at the Annual Conference of the Canadian Association for Population

Therapeutics, Quebec City QC, March 2003. Abstract published in The Canadian Journal of

Clinical Pharmacology 2003;10(1):28.

Vik SA, Maxwell CJ, Hogan DB, Patten SB, Johnson JA, Mitchell C, Romonko-Slack L. “Medication

Adherence and Health Outcomes among Elderly Home Care Clients”, presented at the Annual

Conference of the Canadian Association for Population Therapeutics, Quebec City QC,

March 2003. Abstract published in The Canadian Journal of Clinical Pharmacology

2003;10(1):43.


Vik SA, Maxwell CJ, Hogan DB, Patten SB, Johnson JA, Mitchell C, Romonko-Slack L. “Potentially

Inappropriate Medication Use and Adverse Health Outcomes among Elderly Home Care

Clients”, presented at the Annual Conference of the Canadian Association for Population

Therapeutics, Quebec City QC, March 2003. Abstract published in The Canadian Journal of

Clinical Pharmacology 2003;10(1):46.

Victorino C, Vik SA, Maxwell CJ, Hogan DB, Patten SB. “The Prevalence and Management of Pain

among Elderly Home Care Clients”, presented at the Annual Conference of the Canadian

Association for Population Therapeutics, Quebec City QC, March 2003. Abstract published in

The Canadian Journal of Clinical Pharmacology 2003;10(1):49.

Hogan DB, Maxwell CJ, Ebly EM. “Use of Complementary and Alternative Medicines by Individuals

with Dementia” (oral presentation) presented at the 22nd Annual Scientific Meeting of the

Canadian Geriatrics Society, Montreal QC, October 2002. Abstract published in Geriatrics

Today: Journal of the Canadian Geriatrics Society 2002;5(3):120.

Basran J, Hogan DB, Maxwell CJ, Ebly EM. “Use of Anticholinergic Medications by Individuals

with Dementia” (oral presentation) presented at the 22nd Annual Scientific Meeting of the

Canadian Geriatrics Society, Montreal QC, October 2002. Abstract published in Geriatrics

Today: Journal of the Canadian Geriatrics Society 2002;5(3):122.

Maxwell CJ, Jelinski SE, Ghali WA, Parsons GA. “Management of Acute Myocardial Infarction

among Women and Men in Calgary Alberta”, (oral presentation) presented at the Annual

Conference of the Canadian Association for Population Therapeutics, Toronto ON, April

2002. Abstract published in The Canadian Journal of Clinical Pharmacology 2002;9(1):22.

Vik SA, Maxwell CJ, Hogan DB, Patten SB, Johnson JA, Mitchell C, Romonko-Slack L, Copeland

M, Couchman S, Matson B, Harbidge T. “Assessment of Medication Adherence in the Real

World: Is Pill Count Data Useful?”, presented at the Annual Conference of the Canadian

Association for Population Therapeutics, Toronto ON, April 2002. Abstract published in The

Canadian Journal of Clinical Pharmacology 2002;9(1):28.

Stoian CA, Russell ML, Maxwell CJ. “Prevalence and Correlates of Influenza Immunization in the

Canadian Population”, presented at the Annual Conference of the Canadian Association for

Population Therapeutics, Toronto ON, April 2002. Abstract published in The Canadian

Journal of Clinical Pharmacology 2002;9(1):44.

Stoian CA, Russell ML, Verhoef MJ, Maxwell CJ. “Prevalence of Alternative Practitioner Use in the

Canadian Population”, presented at the Annual Conference of the Canadian Association for

Population Therapeutics, Toronto ON, April 2002. Abstract published in The Canadian

Journal of Clinical Pharmacology 2002;9(1):45.

Maxwell CJ. “An Examination of Medication Use among Older Home Care Clients using the MDS-

HC” presented at the First Joint U.S. & Canadian Case Mix and Quality Assurance

Conference (New Frontiers in Health Information – CIHI and interRAI), Niagara Falls ON,

October 28-31, 2001.

Maxwell CJ, Hogan DB, Ebly EM. “Folate levels, dementia and cerebrovascular outcomes in the

elderly”, poster presented at the 2001 Congress of Epidemiology, Toronto ON, June 2001.

Abstract published in the American Journal of Epidemiology (supplement) 2001;153(11):S57.

Maxwell CJ, Bancej CM, Snider J. “Predictors of mammography use among Canadian women aged

50-69”, poster presented at the 2001 Congress of Epidemiology, Toronto ON, June 2001.

Abstract published in the American Journal of Epidemiology (supplement) 2001;153(11):S37.


Maxwell CJ, Bancej CM, Snider J. “Barriers to cervical cancer screening among Canadian women”,

poster presented at the 2001 Congress of Epidemiology, Toronto ON, June 2001. Abstract

published in the American Journal of Epidemiology (supplement) 2001;153(11):S248.

Bancej CM, Maxwell CJ, Snider J. “Inconsistent self-reported mammography history in a national

longitudinal health survey”, poster presented at the 2001 Congress of Epidemiology, Toronto

ON, June 2001. Abstract published in the American Journal of Epidemiology (supplement)

2001:153(11):S249.

Bancej CM, Maxwell CJ, Bouchard F. “Two-year predictors of mammography uptake and

compliance”, poster presented at the 2001 Congress of Epidemiology, Toronto ON, June

2001. Abstract published in the American Journal of Epidemiology (supplement)

2001:153(11):S250.

Maxwell CJ, Hogan DB, Ebly EM. “Folate levels, dementia and cerebrovascular outcomes in the

elderly”, presented at the Annual Conference of the Canadian Association for Population

Therapeutics, Banff AB, April 2001. Abstract published in The Canadian Journal of Clinical

Pharmacology 2001;8(1): 31.

Maxwell CJ, Hogan DB, Ebly EM. “Prevalence and Consequences of Potentially Inappropriate

Medications in Seniors”, presented at the Annual Conference of the Canadian Association for

Population Therapeutics, Banff AB, April 2001. Abstract published in The Canadian Journal

of Clinical Pharmacology 2001;8(1): 35.

Vik SA, Maxwell CJ, Hogan DB, Patten SB, Johnson JA, Mitchell C, Romonko-Slack L, Copeland

M, Couchman S, Matson B, Harbridge T. “Drug adherence among older urban and rural

home care clients”, presented at the Annual Conference of the Canadian Association for

Population Therapeutics, Banff AB, April 2001. Abstract published in The Canadian Journal

of Clinical Pharmacology 2001;8(1): 29.

Mitchell C, Johnson JA, Maxwell CJ, Vik SA, Hogan DB, Romonko-Slack L, Patten SB, Copeland

M, Couchman S, Matson B, Harbridge T. “Reliability of likert-type versus dichotomous

response options for a standardized self-report measure of medication compliance behaviour”,

presented at the Annual Conference of the Canadian Association for Population Therapeutics,

Banff AB, April 2001. Abstract published in The Canadian Journal of Clinical Pharmacology

2001;8(1): 36.

Stoian CA, Russell ML, Maxwell CJ. “Trend in adult influenza vaccination in Canada”, presented at

the Annual Conference of the Canadian Association for Population Therapeutics, Banff AB,

April 2001. Abstract published in The Canadian Journal of Clinical Pharmacology 2001;8(1):

38.

Maxwell CJ, Hirdes JP. “Overview of RAI/MDS 2.0 for Assessment, Care-planning, Quality

Monitoring and Funding of Long Term Care in Canada” presented to the Tri-Regional

Steering Committee for RAI/MDS 2.0 (RAI-MED) Pilot, Calgary AB, Dec 4, 2000.

Maxwell CJ (Conference Chair). “RAI / MDS Research and Demonstration Projects in Canada” Pre-

Conference Workshop presented at the 29th Annual Scientific and Educational Meeting of the

Canadian Association on Gerontology, Edmonton AB Oct 26, 2000.

Maxwell CJ, Hirdes JP, Hogan DB. “Quality / Research Applications of MDS-HC: Focus on

Medication Issues” presented at the 29th Annual Scientific and Educational Meeting of the

Canadian Association on Gerontology (RAI/MED pre-conference workshop), Edmonton AB

Oct 26, 2000.


Russell ML, Maxwell CJ. “The prevalence and correlates of influenza vaccination among Home Care

clients” presented at the Canadian Society for Clinical Investigation, The Royal College of

Physicians & Surgeons of Canada 2000 Annual Meeting, Edmonton AB, Sept 23, 2000.

Abstract published in Clinical and Investigative Medicine 2000;23(4):S6.

Russell ML, Maxwell CJ. “The prevalence and correlates of influenza vaccination among Home Care

clients” presented at the 34th National Immunization Conference, Washington DC, July5-8,

2000.

Maxwell CJ. “Medical co-morbidities in geriatric psychiatry patients in Alberta: A study based on the

RAI-Mental Health” presented at the Canadian RAI/MDS workshop – National Case Mix

Reimbursement and Quality Assurance Conference, Madison Wisconsin, May 22-24, 2000.

Maxwell CJ, Hogan DB, Howard MI, Ebly EM, Patten SB. “Antihypertensives and depression risk in

the elderly”, presented at the Canadian Forum for Population Therapeutics, Montreal, QC,

May 2000. Abstract published in The Canadian Journal of Clinical Pharmacology 2000;7(1):

65.

Patten SB, Maxwell CJ, Thurston WE, Casebeer A, Russell ML. “Major depression and

antidepressant use in relation to age in a predominantly rural Alberta health region”,

presented at the Canadian Forum for Population Therapeutics, Montreal, QC, May 2000.

Abstract published in The Canadian Journal of Clinical Pharmacology 2000;7(1): 67.

Russell ML, Patten SB, Maxwell CJ, Thurston WE, Casebeer AL, Vollman AR, Verhoef MJ.

“Depression and the use of alternative therapy providers in rural Alberta”, presented at the

Canadian Forum for Population Therapeutics, Montreal, QC, May 2000. Abstract published

in The Canadian Journal of Clinical Pharmacology 2000;7(1): 69.

Neutel CI, Desjardins-Denault S, Maxwell CJ. “New drug starts and risk of falls in nursing homes”,

presented at the International Society for Pharmacoepidemiology Annual Conference, Boston,

MA, August, 1999. Abstract published in Pharmacoepidemiology and Drug Safety 1999;8

(suppl 2), p S157.

Maxwell CJ, Hogan DB, Campbell NRC, Ebly EM. “Nifedipine and mortality risk in the elderly:

relevance of drug formulation, dose and duration”, presented at the Canadian Forum for

Population Therapeutics, Halifax, NS, May 1999. Abstract published in The Canadian Journal

of Clinical Pharmacology 1999; 6(1):47.

Carpenter GI, Maxwell CJ. “Audit of the clinical content of medical and nursing admission

assessments”, presented at the Spring Meeting of the British Geriatrics Society, University

College, Cork, Ireland, April 8-10, 1999. Abstract published in Age and Ageing 1999;28

(suppl. 2), 35.

Carpenter GI, Gill S, Potter J, Maxwell CJ. “A comparison of MDS/RAI activity of daily living,

cognitive performance and depression scales with widely used scales”, presented at the Spring

Meeting of the British Geriatrics Society, University College, Cork, Ireland, April 8-10, 1999.

Abstract published in Age and Ageing 1999;28 (suppl. 2), 29.

Desjardins-Denault S, Dolliver L, Maxwell CJ, Boulianne R, Soucie P. “The Incidence and Nature of

Falls in a Long Term Care Setting”, presented at the 27th Annual Scientific and Educational

Meeting of the Canadian Association on Gerontology, Halifax, October 16, 1998.


Maxwell CJ, Hogan DB, Ebly EM. “Adverse Cognitive Effects of Antihypertensive Treatment?”,

presented at the 6th Canadian Pharmacoepidemiology Forum, Ottawa, ON, April, 1998.

Abstract published in The Canadian Journal of Clinical Pharmacology 1998;5(1):59.

Turcotte KE, Maxwell CJ, Walop W. “Potentially Inappropriate medication use among high-risk

elderly day hospital patients”, presented at the 6th Canadian Pharmacoepidemiology Forum,

Ottawa, ON, April, 1998. Abstract published in The Canadian Journal of Clinical


Desjardins-Denault S, Maxwell CJ, Dolliver L, Neutel CI, Soucie P, Boulianne R. “The Influence of

Medication on the occurrence of Falls in a Long Term Care Setting: A 1-year Retrospective

Study”, presented at the 6th Canadian Pharmacoepidemiology Forum, Ottawa, ON, April,

1998. Abstract published in The Canadian Journal of Clinical Pharmacology 1998;5(1):58.

Maxwell CJ, Neutel CI, Soucie P, Choinard JA. “An Examination of the Appropriateness of

Antibiotic Drug Use among an Institutionalized Elderly Sample”, presented at the 5th

Canadian Pharmacoepidemiology Forum, Hamilton, ON, April, 1997. Abstract published in

The Canadian Journal of Clinical Pharmacology 1997;4(1):49.

Neutel CI, Maxwell CJ. “The Effect of Alcohol Abuse on the Association between NSAID use and

Gastrointestinal Complication”, presented at the 5th Canadian Pharmacoepidemiology Forum,

Hamilton, ON, April, 1997. Abstract published in The Canadian Journal of Clinical


Maxwell CJ (Chair) “Disease Prevention and Health Promotion in Older Women: Underlying

Assumptions and Research Needs”, pre-conference workshop (accredited by the Canadian

Association of Family Physicians and Royal College of Physicians and Surgeons) of the 25th

Annual Scientific and Educational Meeting of the Canadian Association on Gerontology,

Quebec City, October 17, 1996.

Maxwell CJ, Tamblyn R, Neutel CI. “NSAID Therapy in the Management of Arthritis”, presented at

the 25th Annual Scientific and Educational Meeting of the Canadian Association on

Gerontology (Pre-Conference Workshop on Disease Prevention and Health Promotion in

Older Women: Underlying Assumptions and Research Needs), Quebec City, October 17,

1996.

Maxwell CJ, Neutel CI. “Are Hospitalizations for injury after Benzodiazepine Use Preventable?”,

presented at the Canadian Pharmacoepidemiology Forum, Saskatoon, SK, April, 1996.

Neutel CI, Maxwell CJ. “Preventable Morbidity in the Elderly?? Hospitalization for injury after

Benzodiazepine Use”, presented at the 5th Asia-Oceania Regional Congress of Gerontology,

Hong Kong, November, 1995.

Maxwell CJ, Neutel CI, Turcotte K. “Age Differences in risks for GI Complications associated with

NSAID use and other Risk Factors among the Community-Based Elderly”, presented at the

24th Annual Scientific and Educational Meeting of the Canadian Association on Gerontology,

Vancouver, BC, October 1995.

Maxwell CJ, Soucie P, Chouinard JA, Baker D. “An Examination of the Appropriateness of

Antibiotic Drug Use among an Institutionalized Elderly Sample”, presented at the 24th Annual

Scientific and Educational Meeting of the Canadian Association on Gerontology, Vancouver,

BC, October 1995.


Fletcher PC, Hirdes JP, Maxwell CJ. “Risk Factors for Falls Among Institutionalized Seniors”,

presented at the 24th Annual Scientific and Educational Meeting of the Canadian Association

on Gerontology, Vancouver, BC, October 1995.

Maxwell CJ, Neutel CI, Turcotte K. “Gastrointestinal Complications in a population of NSAID users

– A Case-Control Approach”, presented at the Canadian Pharmacoepidemiology Forum,

Montreal, Quebec, May 1995.

Maxwell CJ, Neutel CI, Hirdes JP. “A Prospective Study of Falls after a First and after a Third

Benzodiazepine Prescription”, presented at the 23rd Annual Scientific and Educational

Meeting of the Canadian Association on Gerontology, Winnipeg, Manitoba, October 1994.

Maxwell CJ, Hirdes JP. “An Examination of the Interrelationships between Dementia, Behavioural

Disturbances and Psychotropic Drug Use among Institutionalized Patients”, presented at the

13th Annual Conference of the Ontario Gerontology Association, Toronto, ON, May 1994.

Maxwell CJ, Hirdes JP, Mather JF. “Psychotropic Drug Use and the Management of Behavioural

Problems in a Longitudinal Study of Chronic Hospital Patients”, presented at the Canadian

Pharmacoepidemiology Forum, Toronto, ON, April 1994.

Hirdes JP, Neutel CI, Maxwell CJ. “Recent Benzodiazepine Prescriptions and Hospitalization for

Falls”, presented at the Canadian Pharmacoepidemiology Forum, Toronto, ON, April 1994.

Hirdes JP, Forbes WF, Brown KS, Maxwell CJ. “30-Year Mortality and Quality of Life among

Ontario Males: Results from the 1990 Ontario Longitudinal Study on Aging”, Tijdscnrift voor

Sociale Gezondheidszorg 1993, 71, 39.

Maxwell CJ. “Changes in Self-Rated Health and Mortality among Males in the Ontario Longitudinal

Study of Aging”, presented at the 22nd Annual Scientific and Educational Meeting of the

Canadian Association on Gerontology, Montreal, Quebec, October 1993.

Hirdes JP, Strain LA, Weinberg LE, Payne BJ, Locker D, Hanlon K, Maxwell CJ (Moderator).

“Perspectives on Health Promotion in Later Life”, symposium presented at the 22nd Annual

Scientific and Educational Meeting of the Canadian Association on Gerontology, Montreal,

Quebec, October 1993.

Hirdes JP, Forbes WF, Brown KS, Maxwell CJ. “30-Year Mortality and Quality of Life among

Ontario Males: Results from the 1990 Ontario Longitudinal Study of Aging”, presented at the

International Conference on Chronic Diseases and Changing Patterns in an Aging Society,

Amsterdam, The Netherlands, June 1993.

Hirdes JP, Neutel CI, Maxwell CJ. “An Event History Analysis of the Association between Falls and

Benzodiazepine Use among the Institutionalized Elderly”, presented at the 12th Annual

Conference of the Ontario Gerontology Association, Toronto, ON, May 1993.

Hirdes JP, Neutel CI, Maxwell CJ, Hentschel M, Fisher R. “The Association of Benzodiazepine Use

with Mortality among the Institutionalized Elderly”, presented at the Canadian

Pharmacoepidemiology Forum, Toronto, ON, May 1993.

Maxwell CJ, Hirdes JP, Edlund M. “A Longitudinal Examination of Correlates and Outcomes

Associated with Medication Use Among Older Adults in a Long Term Care Facility”,

presented at the 20th Annual Scientific and Educational Meeting of the Canadian Association

on Gerontology, Toronto, ON, 1991.


Maxwell CJ. “The Effects of Cigarette Smoking on Quality of Life Among the Elderly”, presented at

the 19th Annual Scientific and Educational Meeting of the Canadian Association on

Gerontology, Victoria, BC, 1990.

Maxwell CJ, Jarvie S, Hirdes JP. “Assessment of Body Composition Among the Elderly”, presented

at the Annual Meeting of the Ontario Gerontology Association, Kitchener, ON, 1990.

XI. OTHER COMMUNITY SERVICE

Sept 2015-present Volunteer, Hospice Waterloo

2008 Big Brothers/Sisters, Calgary

date prepared june, 2017 curriculum vitae colleen j...

Documents